<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Bristol-Myers Squibb - Wikipedia</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"XpmqeQpAIIIAAugMc98AAADM","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Bristol-Myers_Squibb","wgTitle":"Bristol-Myers Squibb","wgCurRevisionId":951494000,"wgRevisionId":951494000,"wgArticleId":496995,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Bristol-Myers_Squibb","wgRelevantArticleId":496995,"wgIsProbablyEditable":!0,"wgRelevantPageIsProbablyEditable":!0,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":!0,"wgMediaViewerEnabledByDefault":!0,
"wgPopupsReferencePreviews":!1,"wgPopupsConflictsWithNavPopupGadget":!1,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFMode":"stable","wgMFAmc":!1,"wgMFAmcOutreachActive":!1,"wgMFAmcOutreachUserEligible":!1,"wgMFLazyLoadImages":!0,"wgMFDisplayWikibaseDescriptions":{"search":!0,"nearby":!0,"watchlist":!0,"tagline":!1},"wgMFIsPageContentModelEditable":!0,"wgWMESchemaEditAttemptStepOversample":!1,"wgULSCurrentAutonym":"English","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q266423","wgCentralAuthMobileDomain":!0,"wgEditSubmitButtonLabelPublish":!0,"wgMinervaPermissions":{"watch":!0,"talk":!1},"wgMinervaFeatures":{"beta":!1,"mobileOptionsLink":!0,"categories":!1,"pageIssues":!0,"talkAtTop":!1,"historyInPageActions":!1,"overflowSubmenu":!1,"tabsOnSpecials":!1,"personalMenu":!1,"mainMenuExpanded":!1,"simplifiedTalk":!0},"wgMinervaDownloadNamespaces":[0]};RLSTATE={
"site.styles":"ready","noscript":"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","skins.minerva.base.styles":"ready","skins.minerva.content.styles":"ready","skins.minerva.content.styles.images":"ready","mediawiki.hlist":"ready","mediawiki.ui.icon":"ready","mediawiki.ui.button":"ready","skins.minerva.icons.wikimedia":"ready","skins.minerva.mainMenu.icons":"ready","skins.minerva.mainMenu.styles":"ready","mobile.init.styles":"ready","ext.wikimediaBadges":"ready"};RLPAGEMODULES=["site","mediawiki.page.startup","skins.minerva.options","skins.minerva.scripts","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","mobile.init","ext.relatedArticles.readMore.bootstrap","ext.eventLogging","ext.wikimediaEvents","ext.navigationTiming","mw.externalguidance.init","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.cite.styles%7Cext.wikimediaBadges%7Cmediawiki.hlist%7Cmediawiki.ui.button%2Cicon%7Cmobile.init.styles%7Cskins.minerva.base.styles%7Cskins.minerva.content.styles%7Cskins.minerva.content.styles.images%7Cskins.minerva.icons.wikimedia%7Cskins.minerva.mainMenu.icons%2Cstyles&amp;only=styles&amp;skin=minerva"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=minerva&amp;target=mobile"></script>
<meta name="generator" content="MediaWiki 1.35.0-wmf.28"/>
<meta name="referrer" content="origin"/>
<meta name="referrer" content="origin-when-crossorigin"/>
<meta name="referrer" content="origin-when-cross-origin"/>
<meta name="theme-color" content="#eaecf0"/>
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Bristolmyersprincetonfacility.jpg/1200px-Bristolmyersprincetonfacility.jpg"/>
<meta name="viewport" content="initial-scale=1.0, user-scalable=yes, minimum-scale=0.25, maximum-scale=5.0, width=device-width"/>
<link rel="manifest" href="/w/api.php?action=webapp-manifest"/>
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit"/>
<link rel="edit" title="Edit this page" href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit"/>
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png"/>
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd"/>
<link rel="license" href="//creativecommons.org/licenses/by-sa/3.0/"/>
<link rel="canonical" href="https://en.wikipedia.org/wiki/Bristol-Myers_Squibb"/>
<link rel="dns-prefetch" href="//login.wikimedia.org"/>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Bristol-Myers_Squibb rootpage-Bristol-Myers_Squibb stable issues-group-B skin-minerva action-view">
<div id="mw-mf-viewport">
	<div id="mw-mf-page-center">
		<a class="mw-mf-page-center__mask" href="#"></a>
		<header class="header-container header-chrome">
			<form class="header" action="/w/index.php" method="get">
				<nav class="navigation-drawer toggle-list view-border-box">
					<input type="checkbox" id="main-menu-input" class="toggle-list__checkbox" role="button" aria-labelledby="mw-mf-main-menu-button">
					<label for="main-menu-input" id="mw-mf-main-menu-button"
						class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-menu-base20 mw-ui-icon-flush-left toggle-list__toggle"
						title="Open main menu" data-event-name="ui.mainmenu">Open main menu</label>
					<div id="mw-mf-page-left" class="menu toggle-list__list view-border-box">
	<ul id="p-navigation">
			<li class="">
			    <a href="/wiki/Main_Page" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-home" data-event-name="menu.home"><span>Home</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Special:Random#/random" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-die " data-event-name="menu.random"><span>Random</span></a>
			</li>
			<li class="jsonly">
			    <a href="/wiki/Special:Nearby" class="mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-mapPin nearby" data-event-name="menu.nearby"><span>Nearby</span></a>
			</li>
	</ul>
	<ul id="p-personal">
			<li class="">
			    <a href="/w/index.php?title=Special:UserLogin&amp;returnto=Bristol-Myers+Squibb" class="menu__item--login mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-logIn " data-event-name="menu.login"><span>Log in</span></a>
			</li>
	</ul>
	<ul id="pt-preferences">
			<li class="jsonly">
			    <a href="/w/index.php?title=Special:MobileOptions&amp;returnto=Bristol-Myers+Squibb" class="menu__item--settings mw-ui-icon mw-ui-icon-before mw-ui-icon-minerva-settings " data-event-name="menu.settings"><span>Settings</span></a>
			</li>
	</ul>
	<ul class="hlist">
			<li class="">
			    <a href="/wiki/Wikipedia:About" class="" data-event-name=""><span>About Wikipedia</span></a>
			</li>
			<li class="">
			    <a href="/wiki/Wikipedia:General_disclaimer" class="" data-event-name=""><span>Disclaimers</span></a>
			</li>
	</ul>
</div>

					<label class="main-menu-mask" for="main-menu-input"></label>
				</nav>
				<div class="branding-box">
					<a href="/wiki/Main_Page">
						<span><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></span>
						
					</a>
				</div>
				<div class="search-box">
					<input class="search mw-ui-background-icon-search skin-minerva-search-trigger" type="search" name="search" id="searchInput"
						autocomplete="off" placeholder="Search Wikipedia" aria-label="Search Wikipedia"
						value="">
				</div>
				<nav class="minerva-user-navigation" aria-label="User navigation">
					<div><button id="searchIcon" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-search-base20 skin-minerva-search-trigger" type="submit">Search</button></div>
					
				</nav>
			</form>
		</header>
		<main id="content" class="mw-body">
			<div class="banner-container">
			<div id="siteNotice"></div>
			</div>
			
			<div class="pre-content heading-holder">
				<div class="page-heading">
					<h1 id="section_0">Bristol-Myers Squibb</h1>
					<div class="tagline"></div>
				</div>
				<nav class="page-actions-menu">
	<ul id="page-actions" class="page-actions-menu__list">
		<li id="language-selector" class="page-actions-menu__list-item">
				<a id="" href="/wiki/Special:MobileLanguages/Bristol-Myers_Squibb" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-language-base20 mw-ui-icon-with-label-desktop language-selector"
					data-mw="interface"
					data-event-name="menu.languages" role="button" title="Language">Language</a>
		</li>
		<li id="page-actions-watch" class="page-actions-menu__list-item">
				<a id="ca-watch" href="/w/index.php?title=Special:UserLogin&amp;returnto=Bristol-Myers+Squibb" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-star-base20 mw-ui-icon-with-label-desktop watch-this-article mw-watchlink menu__item--page-actions-watch"
					data-mw="interface"
					data-event-name="menu.watch" role="button" title="Watch">Watch</a>
		</li>
		<li id="page-actions-edit" class="page-actions-menu__list-item">
				<a id="ca-edit" href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=0" class="edit-page menu__item--page-actions-edit mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 mw-ui-icon-with-label-desktop"
					data-mw="interface"
					data-event-name="menu.edit" role="button" title="Edit the lead section of this page">Edit</a>
		</li>
	</ul>
</nav>
<!-- version 1.0.2 (change every time you update a partial) -->

				
				
				<div class="minerva__subtitle"></div>
			</div>
			
			<div id="bodyContent" class="content"><div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><script>function mfTempOpenSection(id){var block=document.getElementById("mf-section-"+id);block.className+=" open-block";block.previousSibling.className+=" open-block";}</script><div class="mw-parser-output"><section class="mf-section-0" id="mf-section-0">
<div role="note" class="hatnote navigation-not-searchable">"Squibb" redirects here. It is not to be confused with <a href="/wiki/Squib_(disambiguation)" class="mw-redirect mw-disambig" title="Squib (disambiguation)">Squib (disambiguation)</a>.</div>
<table class="box-Recentism plainlinks metadata ambox ambox-style ambox-Recentism" role="presentation"><tbody><tr><td class="mbox-text"><div class="mbox-text-span">This article <b>appears to be <a href="/wiki/Wikipedia:Recentism" title="Wikipedia:Recentism">slanted towards recent events</a>.</b><span class="hide-when-compact"> Please try to keep recent events in historical perspective and add more content related to non-recent events.</span>  <small class="date-container"><i>(<span class="date">January 2020</span>)</i></small><small class="hide-when-compact"><i> (<a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a>)</i></small></div></td></tr></tbody></table><p class="mw-empty-elt">
</p>
<p><b>Bristol Myers Squibb Company</b> is an American <a href="/wiki/Pharmaceutical_company" class="mw-redirect" title="Pharmaceutical company">pharmaceutical company</a>, headquartered in <a href="/wiki/New_York_City" title="New York City">New York City</a>.<sup id="cite_ref-2" class="reference"><a href="#cite_note-2">[2]</a></sup></p><table class="infobox vcard" style="width:22em"><caption class="fn org">Bristol Myers Squibb Company</caption><tbody><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Bristol-Myers_Squibb_logo_(2020).svg" class="image"><img alt="Bristol-Myers Squibb logo (2020).svg" src="//upload.wikimedia.org/wikipedia/en/thumb/c/c6/Bristol-Myers_Squibb_logo_%282020%29.svg/220px-Bristol-Myers_Squibb_logo_%282020%29.svg.png" decoding="async" width="220" height="31" srcset="//upload.wikimedia.org/wikipedia/en/thumb/c/c6/Bristol-Myers_Squibb_logo_%282020%29.svg/330px-Bristol-Myers_Squibb_logo_%282020%29.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/c/c6/Bristol-Myers_Squibb_logo_%282020%29.svg/440px-Bristol-Myers_Squibb_logo_%282020%29.svg.png 2x" data-file-width="843" data-file-height="118"></a></td></tr><tr><td colspan="2" class="logo" style="text-align:center"><a href="/wiki/File:Bristolmyersprincetonfacility.jpg" class="image"><img alt="Bristolmyersprincetonfacility.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/a/a6/Bristolmyersprincetonfacility.jpg/250px-Bristolmyersprincetonfacility.jpg" decoding="async" width="250" height="173" data-file-width="2418" data-file-height="1672"></a><div>A Bristol Myers Squibb R&amp;D facility in <a href="/wiki/Lawrence_Township,_Mercer_County,_New_Jersey" title="Lawrence Township, Mercer County, New Jersey">Lawrence</a>, <a href="/wiki/New_Jersey" title="New Jersey">New Jersey</a></div></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/List_of_legal_entity_types_by_country" title="List of legal entity types by country">Type</a></div></th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Public_company" title="Public company">Public</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/Ticker_symbol" title="Ticker symbol">Traded as</a></th><td style="line-height: 1.35em;"><a href="/wiki/New_York_Stock_Exchange" title="New York Stock Exchange">NYSE</a>: <a rel="nofollow" class="external text" href="https://www.nyse.com/quote/XNYS:BMY">BMY</a><br><a href="/wiki/S%26P_100" title="S&amp;P 100">S&amp;P 100</a> component<br><a href="/wiki/S%26P_500" class="mw-redirect" title="S&amp;P 500">S&amp;P 500</a> component</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><a href="/wiki/International_Securities_Identification_Number" title="International Securities Identification Number">ISIN</a></th><td style="line-height: 1.35em;"><span class="plainlinks nourlexpansion"><a class="external text" href="https://tools.wmflabs.org/isin/?language=en&amp;isin=US1101221083">US1101221083 </a><a href="https://www.wikidata.org/wiki/Q266423?uselang=en#P946" title="Edit this on Wikidata"><img alt="Edit this on Wikidata" src="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png" decoding="async" width="10" height="10" style="vertical-align: text-top" srcset="//upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/15px-OOjs_UI_icon_edit-ltr-progressive.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/20px-OOjs_UI_icon_edit-ltr-progressive.svg.png 2x" data-file-width="20" data-file-height="20"></a></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Industry</th><td class="category" style="line-height: 1.35em;"><a href="/wiki/Pharmaceuticals" class="mw-redirect" title="Pharmaceuticals">Pharmaceuticals</a></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Founded</th><td style="line-height: 1.35em;">1887</td></tr><tr><th scope="row" style="padding-right: 0.5em;">Headquarters</th><td class="label" style="line-height: 1.35em;">430 East 29th Street<br><a href="/wiki/New_York_City" title="New York City">New York City</a>, <a href="/wiki/New_York_(state)" title="New York (state)">New York</a>, United States</td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Key people</div></th><td class="agent" style="line-height: 1.35em;"><span class="nowrap">Giovanni Caforio, M.D.</span><br><span class="nowrap"><span style="font-size:85%;">(<a href="/wiki/Chairman#Public_corporations" class="mw-redirect" title="Chairman">Chairman</a> &amp; <a href="/wiki/CEO" class="mw-redirect" title="CEO">CEO</a>)</span></span><br><span class="nowrap">Charles Bancroft</span><br><span class="nowrap"><span style="font-size:85%;">(<a href="/wiki/CFO" class="mw-redirect" title="CFO">CFO</a>)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Revenue</th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <a href="/wiki/US%24" class="mw-redirect" title="US$">US$</a>22.56 billion <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Earnings_before_interest_and_taxes" title="Earnings before interest and taxes">Operating income</a></div></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$</span>5.97 billion <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;"><a href="/wiki/Net_income" title="Net income">Net income</a></div></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$</span>4.95 billion <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Asset" title="Asset">Total assets</a></span></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$</span>34.99 billion <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><span class="nowrap"><a href="/wiki/Equity_(finance)" title="Equity (finance)">Total equity</a></span></th><td style="line-height: 1.35em;"><span class="nowrap"><img alt="Increase" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/11px-Increase2.svg.png" decoding="async" title="Increase" width="11" height="11" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/17px-Increase2.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b0/Increase2.svg/22px-Increase2.svg.png 2x" data-file-width="300" data-file-height="300"> <span style="white-space: nowrap">US$</span>14.13 billion <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;"><div style="padding:0.1em 0;line-height:1.2em;">Number of employees</div></th><td style="line-height: 1.35em;"><span class="nowrap">~23,300 <span style="font-size:85%;">(2018)</span></span></td></tr><tr><th scope="row" style="padding-right: 0.5em;">Website</th><td style="line-height: 1.35em;"><span class="url"><a rel="nofollow" class="external text" href="http://bms.com">BMS.com</a></span></td></tr><tr><td colspan="2" style="text-align:center;line-height: 1.35em;"><b>Footnotes / references</b><br><sup id="cite_ref-10-K_2017_1-0" class="reference"><a href="#cite_note-10-K_2017-1">[1]</a></sup></td></tr></tbody></table><p>Bristol Myers Squibb manufactures prescription pharmaceuticals and biologics in several therapeutic areas, including <a href="/wiki/Cancer" title="Cancer">cancer</a>, <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV/AIDS</a>, <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>, <a href="/wiki/Diabetes" title="Diabetes">diabetes</a>, <a href="/wiki/Hepatitis" title="Hepatitis">hepatitis</a>, <a href="/wiki/Rheumatoid_arthritis" title="Rheumatoid arthritis">rheumatoid arthritis</a> and <a href="/wiki/Psychiatric_disorders" class="mw-redirect" title="Psychiatric disorders">psychiatric disorders</a>.
</p><p>BMS' primary R&amp;D sites are located in <a href="/wiki/Lawrence_Township,_Mercer_County,_New_Jersey" title="Lawrence Township, Mercer County, New Jersey">Lawrence, New Jersey</a> (formerly Squibb, near <a href="/wiki/Princeton,_New_Jersey" title="Princeton, New Jersey">Princeton</a>), <a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick, New Jersey</a>, and <a href="/wiki/Redwood_City,_California" title="Redwood City, California">Redwood City, California</a>; with other sites in <a href="/wiki/Devens,_Massachusetts" title="Devens, Massachusetts">Devens</a> and <a href="/wiki/Cambridge,_Massachusetts" title="Cambridge, Massachusetts">Cambridge, Massachusetts</a>, <a href="/wiki/East_Syracuse,_New_York" title="East Syracuse, New York">East Syracuse, New York</a>, <a href="/wiki/Braine-l%27Alleud" title="Braine-l'Alleud">Braine-l'Alleud, Belgium</a>, <a href="/wiki/Tokyo" title="Tokyo">Tokyo, Japan</a>, and <a href="/wiki/Bangalore" title="Bangalore">Bangalore, India</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3">[3]</a></sup> BMS previously had an R&amp;D site in <a href="/wiki/Wallingford,_Connecticut" title="Wallingford, Connecticut">Wallingford, Connecticut</a> (formerly Bristol-Myers).<sup id="cite_ref-4" class="reference"><a href="#cite_note-4">[4]</a></sup></p>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none"><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul><li class="toclevel-1 tocsection-1"><a href="#History"><span class="tocnumber">1</span> <span class="toctext">History</span></a>
<ul><li class="toclevel-2 tocsection-2"><a href="#Squibb"><span class="tocnumber">1.1</span> <span class="toctext">Squibb</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Bristol-Myers"><span class="tocnumber">1.2</span> <span class="toctext">Bristol-Myers</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Merger"><span class="tocnumber">1.3</span> <span class="toctext">Merger</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#2000_to_2010"><span class="tocnumber">1.4</span> <span class="toctext">2000 to 2010</span></a></li>
<li class="toclevel-2 tocsection-6"><a href="#2011_onward"><span class="tocnumber">1.5</span> <span class="toctext">2011 onward</span></a></li>
<li class="toclevel-2 tocsection-7"><a href="#Corporate_acquisitions_and_divestments_as_Bristol_Myers_Squibb"><span class="tocnumber">1.6</span> <span class="toctext">Corporate acquisitions and divestments as Bristol Myers Squibb</span></a></li>
<li class="toclevel-2 tocsection-8"><a href="#Tree_of_mergers_and_acquisitions"><span class="tocnumber">1.7</span> <span class="toctext">Tree of mergers and acquisitions</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-9"><a href="#Finances"><span class="tocnumber">2</span> <span class="toctext">Finances</span></a></li>
<li class="toclevel-1 tocsection-10"><a href="#Pharmaceuticals"><span class="tocnumber">3</span> <span class="toctext">Pharmaceuticals</span></a>
<ul><li class="toclevel-2 tocsection-11"><a href="#Out_of_production"><span class="tocnumber">3.1</span> <span class="toctext">Out of production</span></a></li>
<li class="toclevel-2 tocsection-12"><a href="#Divested_brands"><span class="tocnumber">3.2</span> <span class="toctext">Divested brands</span></a></li>
</ul></li>
<li class="toclevel-1 tocsection-13"><a href="#Products_under_development"><span class="tocnumber">4</span> <span class="toctext">Products under development</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Scandals"><span class="tocnumber">5</span> <span class="toctext">Scandals</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#See_also"><span class="tocnumber">6</span> <span class="toctext">See also</span></a></li>
<li class="toclevel-1 tocsection-16"><a href="#Notes_and_references"><span class="tocnumber">7</span> <span class="toctext">Notes and references</span></a></li>
<li class="toclevel-1 tocsection-17"><a href="#External_links"><span class="tocnumber">8</span> <span class="toctext">External links</span></a></li>
</ul></div>

</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(1)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="History">History</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=1" title="Edit section: History" data-section="1" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-1 collapsible-block" id="mf-section-1">
<h3 class="in-block"><span class="mw-headline" id="Squibb">Squibb</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=2" title="Edit section: Squibb" data-section="2" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<table class="box-Expand_section plainlinks metadata ambox mbox-small-left ambox-content" role="presentation"><tbody><tr><td class="mbox-text"><div class="mbox-text-span">This section <b>needs expansion</b>. <small>You can help by <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=">adding to it</a>.</small>  <small class="date-container"><i>(<span class="date">January 2020</span>)</i></small></div></td></tr></tbody></table><div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:E.R._Squibb_%26_Son,_Northern_Blvd.,_Long_Island_City._LOC_gsc.5a14902.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/E.R._Squibb_%26_Son%2C_Northern_Blvd.%2C_Long_Island_City._LOC_gsc.5a14902.jpg/220px-E.R._Squibb_%26_Son%2C_Northern_Blvd.%2C_Long_Island_City._LOC_gsc.5a14902.jpg" decoding="async" width="220" height="155" class="thumbimage" data-file-width="560" data-file-height="395"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 155px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/3/36/E.R._Squibb_%26_Son%2C_Northern_Blvd.%2C_Long_Island_City._LOC_gsc.5a14902.jpg/220px-E.R._Squibb_%26_Son%2C_Northern_Blvd.%2C_Long_Island_City._LOC_gsc.5a14902.jpg" data-alt="" data-width="220" data-height="155" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:E.R._Squibb_%26_Son,_Northern_Blvd.,_Long_Island_City._LOC_gsc.5a14902.jpg" class="internal" title="Enlarge"></a></div>E.R. Squibb &amp; Son facility in Long Island City, New York, in 1948</div></div></div>
<p>The Squibb corporation was founded in 1858 by <a href="/wiki/Edward_Robinson_Squibb" class="mw-redirect" title="Edward Robinson Squibb">Edward Robinson Squibb</a> in <a href="/wiki/Brooklyn,_New_York" class="mw-redirect" title="Brooklyn, New York">Brooklyn</a>, New York.<sup id="cite_ref-5" class="reference"><a href="#cite_note-5">[5]</a></sup><sup id="cite_ref-6" class="reference"><a href="#cite_note-6">[6]</a></sup> Squibb was known as an advocate of quality control and high purity standards early within the pharmaceutical industry.<sup id="cite_ref-7" class="reference"><a href="#cite_note-7">[7]</a></sup> He went on to self-publish an alternative to the <a href="/wiki/United_States_Pharmacopeia" title="United States Pharmacopeia">U.S. Pharmacopeia</a> titled <i>Squibb's Ephemeris of Materia Medica,</i> after failing to convince the <a href="/wiki/American_Medical_Association" title="American Medical Association">American Medical Association</a> to incorporate higher purity standards.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">[8]</a></sup> <i>Materia Medica</i>, Squibb products, and Edward Squibb's opinion on the fundamentals of pharmacy are found in many medical papers of the late 1800s.<sup id="cite_ref-9" class="reference"><a href="#cite_note-9">[9]</a></sup><sup id="cite_ref-10" class="reference"><a href="#cite_note-10">[10]</a></sup><sup id="cite_ref-11" class="reference"><a href="#cite_note-11">[11]</a></sup><sup id="cite_ref-12" class="reference"><a href="#cite_note-12">[12]</a></sup> The <i><a href="/wiki/American_Journal_of_Pharmaceutical_Education" title="American Journal of Pharmaceutical Education">American Journal of Pharmacy</a></i> published more than one hundred papers of Squibb's research surrounding the industry.<sup id="cite_ref-13" class="reference"><a href="#cite_note-13">[13]</a></sup></p><p>Squibb Corporation served as a major supplier of medical goods to the Union Army during the <a href="/wiki/American_Civil_War" title="American Civil War">American Civil War</a>, providing portable medical kits containing <a href="/wiki/Morphine" title="Morphine">morphine</a>, surgical anesthetics, and <a href="/wiki/Quinine" title="Quinine">quinine</a> for the treatment of malaria (which was endemic in most of the eastern United States at that time).<sup id="cite_ref-14" class="reference"><a href="#cite_note-14">[14]</a></sup><sup id="cite_ref-15" class="reference"><a href="#cite_note-15">[15]</a></sup></p><p>In 1944, Squibb opened the world's largest penicillin plant in <a href="/wiki/New_Brunswick,_New_Jersey" title="New Brunswick, New Jersey">New Brunswick, New Jersey</a>.<sup id="cite_ref-16" class="reference"><a href="#cite_note-16">[16]</a></sup></p>
<div style="clear:both;"></div>
<h3 class="in-block"><span class="mw-headline" id="Bristol-Myers">Bristol-Myers</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=3" title="Edit section: Bristol-Myers" data-section="3" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<table class="box-Expand_section plainlinks metadata ambox mbox-small-left ambox-content" role="presentation"><tbody><tr><td class="mbox-text"><div class="mbox-text-span">This section <b>needs expansion</b>. <small>You can help by <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=">adding to it</a>.</small>  <small class="date-container"><i>(<span class="date">January 2020</span>)</i></small></div></td></tr></tbody></table><div class="thumb tright"><div class="thumbinner" style="width:102px;"><a href="/wiki/File:Sal_Hepatica_by_Bristol_Myers_Co_(1909).jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/90/Sal_Hepatica_by_Bristol_Myers_Co_%281909%29.jpg/100px-Sal_Hepatica_by_Bristol_Myers_Co_%281909%29.jpg" decoding="async" width="100" height="197" class="thumbimage" data-file-width="258" data-file-height="508"></noscript><span class="lazy-image-placeholder" style="width: 100px;height: 197px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/9/90/Sal_Hepatica_by_Bristol_Myers_Co_%281909%29.jpg/100px-Sal_Hepatica_by_Bristol_Myers_Co_%281909%29.jpg" data-alt="" data-width="100" data-height="197" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Sal_Hepatica_by_Bristol_Myers_Co_(1909).jpg" class="internal" title="Enlarge"></a></div>Sal Hepatica (1909)</div></div></div>
<p>In 1887, <a href="/wiki/Hamilton_College_(New_York)" class="mw-redirect" title="Hamilton College (New York)">Hamilton College</a> graduates <a href="/wiki/William_McLaren_Bristol" title="William McLaren Bristol">William McLaren Bristol</a> and <a href="/wiki/John_Ripley_Myers" title="John Ripley Myers">John Ripley Myers</a> purchased the Clinton Pharmaceutical company of <a href="/wiki/Clinton,_Oneida_County,_New_York" title="Clinton, Oneida County, New York">Clinton</a>, New York. In May of 1898, they decided to rename it <b>Bristol, Myers and Company</b>. Following Myers' death in 1899, Bristol changed the name to the <b>Bristol-Myers Corporation</b>. During the 1890s, the company introduced its first nationally recognized product <a href="/wiki/Sal_Hepatica" title="Sal Hepatica">Sal Hepatica</a>, a <a href="/wiki/Laxative" title="Laxative">laxative</a> mineral salt, followed by <a href="/wiki/Ipana" title="Ipana">Ipana</a> toothpaste in 1901.<sup id="cite_ref-MarketingChannels_17-0" class="reference"><a href="#cite_note-MarketingChannels-17">[17]</a></sup><sup id="cite_ref-18" class="reference"><a href="#cite_note-18">[18]</a></sup> Other divisions were Clairol (hair colors and haircare) and Drackett (household products such as Windex and Drano).<sup id="cite_ref-19" class="reference"><a href="#cite_note-19">[19]</a></sup></p><p>In 1943, Bristol-Myers acquired Cheplin Biological Laboratories, a producer of <a href="/wiki/Acidophilus" class="mw-redirect" title="Acidophilus">acidophilus milk</a> in <a href="/wiki/East_Syracuse,_New_York" title="East Syracuse, New York">East Syracuse, New York</a><sup id="cite_ref-20" class="reference"><a href="#cite_note-20">[20]</a></sup>, and converted the plant to produce <a href="/wiki/Penicillin" title="Penicillin">penicillin</a> for the <a href="/wiki/Allies_of_World_War_II" title="Allies of World War II">World War II Allied forces</a>. After the war, the company renamed the plant <a href="/wiki/Bristol_Laboratories" class="mw-redirect" title="Bristol Laboratories">Bristol Laboratories</a> in 1945 and entered the civilian <a href="/wiki/Antibiotics" class="mw-redirect" title="Antibiotics">antibiotics</a> market, where it faced competition from Squibb.<sup id="cite_ref-MarketingChannels_17-1" class="reference"><a href="#cite_note-MarketingChannels-17">[17]</a></sup> Penicillin production at the East Syracuse plant ended in 2005, when it became less expensive to produce overseas.<sup id="cite_ref-21" class="reference"><a href="#cite_note-21">[21]</a></sup><sup id="cite_ref-22" class="reference"><a href="#cite_note-22">[22]</a></sup> The facility continues to be used for the manufacturing process development and production of other <a href="/wiki/Biopharmaceutical" title="Biopharmaceutical">biologic medicines</a> for clinical trials and commercial use.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2020)">citation needed</span></a></i>]</sup></p>
<div style="clear:both;"></div>
<h3 class="in-block"><span class="mw-headline" id="Merger">Merger</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=4" title="Edit section: Merger" data-section="4" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>Bristol-Myers and Squibb merged in 1989 and became Bristol-Myers Squibb.<sup id="cite_ref-23" class="reference"><a href="#cite_note-23">[23]</a></sup></p><p>In 1999, President Clinton awarded Bristol-Myers Squibb the <a href="/wiki/National_Medal_of_Technology" class="mw-redirect" title="National Medal of Technology">National Medal of Technology</a>, the nation's highest recognition for technological achievement, "for extending and enhancing human life through innovative pharmaceutical research and development and for redefining the science of clinical study through groundbreaking and hugely complex clinical trials that are recognized models in the industry."<sup id="cite_ref-24" class="reference"><a href="#cite_note-24">[24]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2000_to_2010">2000 to 2010</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=5" title="Edit section: 2000 to 2010" data-section="5" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0a/Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg/220px-Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg" decoding="async" width="220" height="164" class="thumbimage" data-file-width="2592" data-file-height="1936"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 164px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0a/Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg/220px-Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg" data-alt="" data-width="220" data-height="164" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Bristol-Myers_Squibb_building_at_100_Nassau_Park_Boulevard_2010.jpg" class="internal" title="Enlarge"></a></div>The company has a number of facilities in New Jersey; this one is on the border between West Windsor and Princeton</div></div></div>
<p>In 2002, the company was involved in a lawsuit of illegally maintaining a monopoly on Taxol, its cancer treatment, and it was again sued for the antitrust lawsuit 5 years later, which cost the company $125 million for settlement.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">[25]</a></sup></p><p>The company was involved in an <a href="/wiki/Accounting_scandal" class="mw-redirect" title="Accounting scandal">accounting scandal</a> in 2002 that resulted in a significant restatement of revenues from 1999 to 2001. The restatement was the result of an improper booking of sales related to "<a href="/wiki/Channel_stuffing" title="Channel stuffing">channel stuffing</a>" as the practice of offering excess inventory to customers to create higher sales numbers. The company has since settled with the <a href="/wiki/United_States_Department_of_Justice" title="United States Department of Justice">United States Department of Justice</a> and <a href="/wiki/Securities_and_Exchange_Commission" class="mw-redirect" title="Securities and Exchange Commission">Securities and Exchange Commission</a>, agreeing to pay $150 million while neither admitting nor denying guilt.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">[26]</a></sup></p><p>On October 24, 2002, Bristol-Myers Squibb Co. restated earnings downward for parts of 2000 and 2001 while revising this year's earnings upward because of its massive inventory backlog imbroglio that spurred two government investigations.<sup id="cite_ref-27" class="reference"><a href="#cite_note-27">[27]</a></sup> On March 15, 2004, Bristol-Myers Squibb Co. adjusted upward its fourth-quarter and full-year 2003 results after reversing an earlier decision about how to deal with accounting errors made in prior years.<sup id="cite_ref-28" class="reference"><a href="#cite_note-28">[28]</a></sup> As part of a Deferred Prosecution Agreement, the company was placed under the oversight of a monitor appointed by the U.S. Attorney in <a href="/wiki/New_Jersey" title="New Jersey">New Jersey</a>. In addition, the former head of the Pharma group, Richard Lane, and the ex-CFO, Fred Schiff, were indicted for federal securities violations.
</p>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Plavix_2007-04-19.jpg" class="image"><noscript><img alt="Plavix 2007-04-19.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Plavix_2007-04-19.jpg/170px-Plavix_2007-04-19.jpg" decoding="async" width="170" height="128" class="thumbimage" data-file-width="3648" data-file-height="2736"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 128px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b9/Plavix_2007-04-19.jpg/170px-Plavix_2007-04-19.jpg" data-alt="Plavix 2007-04-19.jpg" data-width="170" data-height="128" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Plavix_2007-04-19.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<p>An investigation of the company was made public in July 2006, and the <a href="/wiki/FBI" class="mw-redirect" title="FBI">FBI</a> raided the company's corporate offices. The investigation centered on the distribution of Plavix and charges of <a href="/wiki/Collusion" title="Collusion">collusion</a>.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29">[29]</a></sup> On September 12, 2006, the monitor, former Federal Judge <a href="/wiki/Frederick_B._Lacey" class="mw-redirect" title="Frederick B. Lacey">Frederick B. Lacey</a>, urged the company to remove then CEO Peter Dolan over the Plavix dispute. Later that day, BMS announced that Dolan would indeed step down.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">[30]</a></sup></p><p>The Deferred Prosecution Agreement expired in June 2007 and the Department of Justice did not take any further legal action against the company for matters covered by the DPA. Under CEO Jim Cornelius, who was CEO following Dolan until May 2010, all executives involved in the "channel-stuffing" and generic competition scandals have since left the company.
</p><p>In 2009, the company began a major restructuring focusing on the pharmaceutical business and biologic products, along with productivity initiatives and cost-cutting and streamlining business operations through a multi-year program of on-going layoffs.  This was part of a business strategy launched in 2007 to transform the company from a large diversified pharmaceutical company to a specialty biopharma company, which also included the closure of half of their manufacturing facilities.<sup id="cite_ref-:1_31-0" class="reference"><a href="#cite_note-:1-31">[31]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>19</span></sup>  As another cost-cutting measure, Bristol-Myers Squibb also reduced health-care subsidies for retirees and plans to freeze their pension plan at the end of 2009.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (August 2009)">citation needed</span></a></i>]</sup></p><p>BMS is a Fortune 500 Company (#114 in 2010 list). Newsweek's 2009 Green Ranking recognized Bristol-Myers Squibb as 8th among 500 of the largest United States corporations. Also, BMS was included in the 2009 Dow Jones Sustainability <a href="/wiki/North_America" title="North America">North America</a> Index of leading sustainability-driven companies.
</p><p><a href="/wiki/Lamberto_Andreotti" title="Lamberto Andreotti">Lamberto Andreotti</a> was named <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> in 2010; he had previously served as "president and <a href="/wiki/Chief_operating_officer" title="Chief operating officer">COO</a> responsible for all pharmaceutical operations worldwide."<sup id="cite_ref-:0_32-0" class="reference"><a href="#cite_note-:0-32">[32]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="2011_onward">2011 onward</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=6" title="Edit section: 2011 onward" data-section="6" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Bristol_Myers_Squibb,_Moreton,_Wirral_-_IMG_0369.JPG" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d3/Bristol_Myers_Squibb%2C_Moreton%2C_Wirral_-_IMG_0369.JPG/220px-Bristol_Myers_Squibb%2C_Moreton%2C_Wirral_-_IMG_0369.JPG" decoding="async" width="220" height="165" class="thumbimage" data-file-width="4320" data-file-height="3240"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 165px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d3/Bristol_Myers_Squibb%2C_Moreton%2C_Wirral_-_IMG_0369.JPG/220px-Bristol_Myers_Squibb%2C_Moreton%2C_Wirral_-_IMG_0369.JPG" data-alt="" data-width="220" data-height="165" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Bristol_Myers_Squibb,_Moreton,_Wirral_-_IMG_0369.JPG" class="internal" title="Enlarge"></a></div>Bristol-Myers Squibb facility in Wirral, England</div></div></div>
<p>In 2011, Lou Schmukler joined the company as the president of global product development and design; Schmukler led the team that completed the company's strategic transformation to a specialty biopharmaceutical company that had begun in 2007.<sup id="cite_ref-:1_31-1" class="reference"><a href="#cite_note-:1-31">[31]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>19</span></sup>  As of 2011, the company had a dozen manufacturing facilities and six product development sites.<sup id="cite_ref-:1_31-2" class="reference"><a href="#cite_note-:1-31">[31]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>19</span></sup></p><p>Citing major developments and a market capitalization of US$87 billion and stock appreciation of 61.4%, Bristol-Myers Squibb was ranked as the best drug company of 2013 by <a href="/wiki/Forbes_(magazine)" class="mw-redirect" title="Forbes (magazine)"><i>Forbes</i> magazine</a>.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">[33]</a></sup></p><p>In December 2014 the company received FDA approval for the use of the <a href="/wiki/PD-1" class="mw-redirect" title="PD-1">PD-1</a> inhibitor <a href="/wiki/Nivolumab" title="Nivolumab">nivolumab</a> (Opdivo) in treating patients whose skin cancer cannot be removed or have not responded to previous drug therapies.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">[34]</a></sup> In February 2015, the company initiated a research partnership with Rigel Pharmaceuticals which could generate more than $339 million. In March, the company obtained an exclusive opportunity to both licence and commercialise <a href="/wiki/PROSTVAC" class="mw-redirect" title="PROSTVAC">PROSTVAC</a>, <a href="/wiki/Bavarian_Nordic" title="Bavarian Nordic">Bavarian Nordic</a>'s phase III prostate specific antigen targeting cancer immunotherapy. Bavarian Nordic would receive an upfront payment of $60 million as well as incremental payments up to $230 million, if the overall survival of test patients exceeds that seen in Phase II tests. Bavarian could also receive milestone payments of between $110 million and $495 million, dependent on regulatory authorization, and these payments have the potential to total up to $975 million.<sup id="cite_ref-35" class="reference"><a href="#cite_note-35">[35]</a></sup></p><p>In May 2015, Dr. Giovanni Caforio became <a href="/wiki/Chief_executive_officer" title="Chief executive officer">CEO</a> of the company;<sup id="cite_ref-ABC_News_36-0" class="reference"><a href="#cite_note-ABC_News-36">[36]</a></sup> Caforio was formerly the company's <a href="/wiki/Chief_operating_officer" title="Chief operating officer">COO</a> and succeeded <a href="/wiki/Lamberto_Andreotti" title="Lamberto Andreotti">Andreotti</a> upon his retirement.<sup id="cite_ref-:0_32-1" class="reference"><a href="#cite_note-:0-32">[32]</a></sup> Andreotti subsequently succeeded James Cornelius as <a href="/wiki/Executive_Chairman" class="mw-redirect" title="Executive Chairman">executive chairman</a> upon his retirement.<sup id="cite_ref-:0_32-2" class="reference"><a href="#cite_note-:0-32">[32]</a></sup></p><p>In late February 2017, the <i><a href="/wiki/Wall_Street_Journal" class="mw-redirect" title="Wall Street Journal">Wall Street Journal</a></i> and <i><a href="/wiki/Fortune_(magazine)" title="Fortune (magazine)">Fortune</a></i>, among others, reported that activist investor, <a href="/wiki/Carl_Icahn" title="Carl Icahn">Carl Icahn</a>, had taken a stake in the company, signalling a potential future takeover<sup id="cite_ref-37" class="reference"><a href="#cite_note-37">[37]</a></sup><sup id="cite_ref-38" class="reference"><a href="#cite_note-38">[38]</a></sup> from the likes of <a href="/wiki/Gilead_Sciences" title="Gilead Sciences">Gilead Sciences</a>.<sup id="cite_ref-39" class="reference"><a href="#cite_note-39">[39]</a></sup></p><p>In April 2018, the company reported net income of $1.5 billion, or 91 cents per share, for the first quarter of the year, thanks to the increased sales of their cancer drug Opdivo.<sup id="cite_ref-40" class="reference"><a href="#cite_note-40">[40]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Corporate_acquisitions_and_divestments_as_Bristol_Myers_Squibb">Corporate acquisitions and divestments as Bristol Myers Squibb</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=7" title="Edit section: Corporate acquisitions and divestments as Bristol Myers Squibb" data-section="7" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Buspar.jpg" class="image"><noscript><img alt="Buspar.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Buspar.jpg/170px-Buspar.jpg" decoding="async" width="170" height="145" class="thumbimage" data-file-width="2080" data-file-height="1778"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 145px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/0b/Buspar.jpg/170px-Buspar.jpg" data-alt="Buspar.jpg" data-width="170" data-height="145" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Buspar.jpg" class="internal" title="Enlarge"></a></div></div></div></div>
<p>In August 2009, during a major restructuring activity, BMS acquired the <a href="/wiki/Biotechnology" title="Biotechnology">biotechnology</a> firm <a href="/wiki/Medarex" title="Medarex">Medarex</a> as part of the company's "String of Pearls" strategy of alliances, partnerships and acquisitions.<sup id="cite_ref-41" class="reference"><a href="#cite_note-41">[41]</a></sup>  In November, Bristol Myers Squibb announced that it was "splitting off" Mead Johnson Nutrition by offering BMY shareholders the opportunity to exchange their stock for shares in Mead Johnson. According to Bristol Myers Squibb, this move was expected to further sharpen the company's focus on biopharmaceuticals.
</p><p>In October 2010, the company acquired ZymoGenetics, securing an existing product as well as pipeline assets in hepatitis C, cancer and other therapeutic areas. 
</p><p>Bristol Myers Squibb agreed to pay around $2.5 billion in cash to buy Inhibitex Inc. in attempt to compete with <a href="/wiki/Gilead" title="Gilead">Gilead</a>/<a href="/wiki/Pharmasset" title="Pharmasset">Pharmasset</a> to produce <a href="/wiki/Hepatitis_C" title="Hepatitis C">Hepatitis C</a> drugs. The settlement will be finished in 2 months for its Inhibitex's shareholders acceptance of 126 percent premium price of its price over the previous 20 trading days ended on January 6.<sup id="cite_ref-42" class="reference"><a href="#cite_note-42">[42]</a></sup> On June 29, Bristol-Myers Squibb extended its portfolio of <a href="/wiki/Diabetes" title="Diabetes">diabetes</a> treatments when it agreed to buy <a href="/wiki/Amylin_Pharmaceuticals" title="Amylin Pharmaceuticals">Amylin Pharmaceuticals</a> for around <span style="white-space: nowrap">US$5.3 billion</span> in cash and pay <span style="white-space: nowrap">US$1.7 billion</span> to <a href="/wiki/Eli_Lilly" title="Eli Lilly">Eli Lilly</a> to cover Amylin's debt and its outstanding collaboration-related obligations.<sup id="cite_ref-:2_43-0" class="reference"><a href="#cite_note-:2-43">[43]</a></sup> <a href="/wiki/Astra_Zeneca" class="mw-redirect" title="Astra Zeneca">AstraZeneca</a>, who already collaborated on several diabetes treatments with Bristol-Myers Squibb, agreed to pay <span style="white-space: nowrap">US$3.4 billion</span> in cash for the right to continue development of Amylin's products.<sup id="cite_ref-:2_43-1" class="reference"><a href="#cite_note-:2-43">[43]</a></sup>  Two years later, in 2014, the company divested Amylin to AstraZeneca.<sup id="cite_ref-:1_31-3" class="reference"><a href="#cite_note-:1-31">[31]</a></sup><sup class="reference" style="white-space:nowrap;">:<span>19</span></sup></p><p>In April 2014, BMS announced its acquisition of iPierian for up to $725 million.<sup id="cite_ref-44" class="reference"><a href="#cite_note-44">[44]</a></sup></p><p>In February 2015, the company acquired Flexus Biosciences for $1.25 billion. As part of this deal, BMS will gain full rights to Flexus' lead small molecule <a href="/wiki/Indoleamine_2,3-dioxygenase#Inhibitors" title="Indoleamine 2,3-dioxygenase">IDO1-inhibitor</a>, F001287.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">[45]</a></sup>  In November, the company acquired the <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> drug developer Cardioxyl for up to $2.075 billion. The deal strengthens the BMS' critical pipelines with the phase II candidate for <a href="/wiki/Acute_decompensated_heart_failure" title="Acute decompensated heart failure">acute decompensated heart failure</a>, <a href="/wiki/CXL-1427" class="mw-redirect" title="CXL-1427">CXL-1427</a>.<sup id="cite_ref-46" class="reference"><a href="#cite_note-46">[46]</a></sup></p><p>In March 2016, the company announced it would acquire Padlock Therapeutics for up to $600 million.<sup id="cite_ref-47" class="reference"><a href="#cite_note-47">[47]</a></sup> In early July, the company announced it would acquire Cormorant Pharmaceuticals for $520 million, boosting BMS' oncology offering through Cormorants <a href="/wiki/Monoclonal_antibody" title="Monoclonal antibody">monoclonal antibody</a> targeted against <a href="/wiki/Interleukin-8" class="mw-redirect" title="Interleukin-8">interleukin-8</a>.<sup id="cite_ref-genengaug2016_48-0" class="reference"><a href="#cite_note-genengaug2016-48">[48]</a></sup></p><p>In August 2017 the company acquired <a href="/wiki/IFM_Therapeutics" title="IFM Therapeutics">IFM Therapeutics</a> for $300 million upfront, with contingency payments of $1.01 billion due on certain milestones – allowing BMS to better compete against <a href="/wiki/Merck_%26_Co" class="mw-redirect" title="Merck &amp; Co">Merck &amp; Co</a>'s cancer rival treatment, <a href="/wiki/Keytruda" class="mw-redirect" title="Keytruda">Keytruda</a>.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">[49]</a></sup></p><p>In early January 2019, the company announced it would acquire <a href="/wiki/Celgene" title="Celgene">Celgene</a> (NASDAQ:CELG) for $74 billion ($95 billion including debt<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">[50]</a></sup>), in a deal that would become the largest pharmaceutical-company acquisition ever.<sup id="cite_ref-51" class="reference"><a href="#cite_note-51">[51]</a></sup>  The Celgene acquisition aimed to be a refresher to the company's pipeline, helping to overcome from declining sales of <a href="/wiki/Opdivo" class="mw-redirect" title="Opdivo">Opdivo</a> relative to competitor <a href="/wiki/Keytruda" class="mw-redirect" title="Keytruda">Keytruda</a>.<sup id="cite_ref-:3_52-0" class="reference"><a href="#cite_note-:3-52">[52]</a></sup>  Under the terms of the deal, Celgene shareholders would receive one BMS share as well as $50 in cash for each Celgene share held, valuing Celgene at $102.43 a share; representing a 54% premium to the previous days closing price.<sup id="cite_ref-53" class="reference"><a href="#cite_note-53">[53]</a></sup>  Investor opposition to this acquisition, leading into an April 12 shareholder vote, appeared when BMS's second-largest investor, <a href="/wiki/Wellington_Management_Company" title="Wellington Management Company">Wellington Management</a>, voiced its opposition, followed by investor <a href="/wiki/Starboard_Value" title="Starboard Value">Starboard Value</a>.<sup id="cite_ref-:3_52-1" class="reference"><a href="#cite_note-:3-52">[52]</a></sup> In April 2019 BMS announced that 75% of its shareholders voted to approve the pending merger with Celgene. Transaction to close in the third quarter of 2019, subject to regulatory approvals.<sup id="cite_ref-54" class="reference"><a href="#cite_note-54">[54]</a></sup>Newly issued BMS shares and CVRs will commence trading on the New York Stock Exchange, with the CVRs trading under the symbol ‘BMYRT'.<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">[55]</a></sup></p><p>The strategic divestment of the company's consumer health business, UPSA, to <a href="/wiki/Taisho_Pharmaceutical" title="Taisho Pharmaceutical">Taisho</a> completed in 2019.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">[56]</a></sup>  UPSA focused product delivery on France and the rest of Europe.  As early as 2005, the company had divested individual consumer products,<sup id="cite_ref-:4_57-0" class="reference"><a href="#cite_note-:4-57">[57]</a></sup><sup id="cite_ref-:5_58-0" class="reference"><a href="#cite_note-:5-58">[58]</a></sup> and its US- and Canada-focused consumer products business.<sup id="cite_ref-:6_59-0" class="reference"><a href="#cite_note-:6-59">[59]</a></sup></p><p>In August the <a href="/wiki/Amgen" title="Amgen">Amgen</a> announced it would acquire the <a href="/wiki/Otezla" class="mw-redirect" title="Otezla">Otezla</a> drug programme from <a href="/wiki/Celgene" title="Celgene">Celgene</a> for $13.4 billion, as part of Celgene and Bristol Myers Squibb's merger deal.<sup id="cite_ref-60" class="reference"><a href="#cite_note-60">[60]</a></sup><sup id="cite_ref-61" class="reference"><a href="#cite_note-61">[61]</a></sup></p><p>In February 2020, Bristol Myers Squibb and partner Biomotiv launched a new company called Anteros Pharmaceuticals, which focuses on creating inflammation and fibrosis medicines. <sup id="cite_ref-62" class="reference"><a href="#cite_note-62">[62]</a></sup></p>
<h3 class="in-block"><span class="mw-headline" id="Tree_of_mergers_and_acquisitions">Tree of mergers and acquisitions</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=8" title="Edit section: Tree of mergers and acquisitions" data-section="8" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Peake_and_Whittingham_Studio.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/3/39/Peake_and_Whittingham_Studio.jpg/220px-Peake_and_Whittingham_Studio.jpg" decoding="async" width="220" height="171" class="thumbimage" data-file-width="1027" data-file-height="796"></noscript><span class="lazy-image-placeholder" style="width: 220px;height: 171px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/3/39/Peake_and_Whittingham_Studio.jpg/220px-Peake_and_Whittingham_Studio.jpg" data-alt="" data-width="220" data-height="171" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Peake_and_Whittingham_Studio.jpg" class="internal" title="Enlarge"></a></div>Photo shoot for a Squibb advertisement, c. 1922</div></div></div>
<div role="note" class="hatnote navigation-not-searchable plainlinks">This list is <a href="/wiki/Wikipedia:WikiProject_Lists#Incomplete_lists" title="Wikipedia:WikiProject Lists">incomplete</a>; you can help by <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit">expanding it</a>.</div>
<p>The following is an illustration of the company's major mergers and acquisitions and historical predecessors:
</p>
<style data-mw-deduplicate="TemplateStyles:r886050385">.mw-parser-output .treeview ul{padding:0;margin:0}.mw-parser-output .treeview li{padding:0;margin:0;list-style-type:none;list-style-image:none}.mw-parser-output .treeview li li{background:url("//upload.wikimedia.org/wikipedia/commons/f/f2/Treeview-grey-line.png")no-repeat 0 -2981px;padding-left:21px;text-indent:0.3em}.mw-parser-output .treeview li li:last-child{background-position:0 -5971px}.mw-parser-output .treeview li.emptyline>ul>.mw-empty-elt:first-child+.emptyline,.mw-parser-output .treeview li.emptyline>ul>li:first-child{background-position:0 9px}</style><div class="treeview">
<ul><li><b>Bristol-Myers Squibb</b> <small>(Formed by the merger of Squibb Corporation (Est 1858) and Bristol-Myers (Est 1887))</small>
<ul><li><a href="/w/index.php?title=Adnexus_Therapeutics&amp;action=edit&amp;redlink=1" class="new" title="Adnexus Therapeutics (page does not exist)">Adnexus Therapeutics</a></li>
<li>ConvaTec</li>
<li>Kosan Biosciences</li>
<li><a href="/wiki/Medarex" title="Medarex">Medarex</a> <small>(Acq 2009)</small></li>
<li><a href="/wiki/ZymoGenetics" title="ZymoGenetics">ZymoGenetics</a> <small>(Acq 2010)</small></li>
<li><a href="/w/index.php?title=Amira_Pharmaceuticals&amp;action=edit&amp;redlink=1" class="new" title="Amira Pharmaceuticals (page does not exist)">Amira Pharmaceuticals</a></li>
<li>Inhibitex Inc <small>(Acq 2012)</small></li>
<li><a href="/wiki/Amylin_Pharmaceuticals" title="Amylin Pharmaceuticals">Amylin Pharmaceuticals</a> <small>(Acq 2012 jointly with <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a>)</small></li>
<li><a href="/w/index.php?title=IPierian&amp;action=edit&amp;redlink=1" class="new" title="IPierian (page does not exist)">iPierian</a> <small>(Acq 2014)</small></li>
<li><a href="/w/index.php?title=Flexus_Biosciences&amp;action=edit&amp;redlink=1" class="new" title="Flexus Biosciences (page does not exist)">Flexus Biosciences</a> <small>(Acq 2015)</small></li>
<li>Cardioxyl <small>(Acq 2015)</small></li>
<li>Padlock Therapeutics <small>(Acq 2016)</small></li>
<li><a href="/w/index.php?title=Cormorant_Pharmaceuticals&amp;action=edit&amp;redlink=1" class="new" title="Cormorant Pharmaceuticals (page does not exist)">Cormorant Pharmaceuticals</a> <small>(Acq 2016)</small></li>
<li><a href="/wiki/IFM_Therapeutics" title="IFM Therapeutics">IFM Therapeutics</a> <small>(Acq 2017)</small></li>
<li><a href="/wiki/Celgene" title="Celgene">Celgene</a> <small>(Acq 2019)</small>
<ul><li>Signal Pharmaceuticals, Inc <small>(Acq 2000)</small></li>
<li>Anthrogenesis <small>(Acq 2002)</small></li>
<li>Pharmion Corporation <small>(Acq 2008)</small></li>
<li>Gloucester Pharmaceuticals <small>(Acq 2009)</small></li>
<li>Abraxis BioScience Inc <small>(Acq 2010)</small></li>
<li>Avila Therapeutics, Inc <small>(Acq 2012)</small></li>
<li>Quanticel <small>(Acq 2015)</small></li>
<li>Receptos <small>(Acq 2015)</small></li>
<li>EngMab AG <small>(Acq 2016)</small></li>
<li>Delinia <small>(Acq 2017)</small></li>
<li>Impact Biomedicines <small>(Acq 2018)</small></li>
<li><a href="/wiki/Juno_Therapeutics" title="Juno Therapeutics">Juno Therapeutics</a> <small>(Acq 2018)</small>
<ul><li>AbVitro <small>(Acq 2016)</small></li>
<li>RedoxTherapies <small>(Acq 2016)</small></li>
<li>Celegene <small>(Acq 2020)</small></li></ul></li></ul></li></ul></li></ul></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(2)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Finances">Finances</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=9" title="Edit section: Finances" data-section="9" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-2 collapsible-block" id="mf-section-2">
<p>For the fiscal year 2017, Bristol Myers Squibb reported earnings of US$1.007 billion, with an annual revenue of US$20.776 billion, an increase of 6.9% over the previous fiscal cycle. Bristol-Myers Squibb's shares traded at over $55 per share, and its market capitalization was valued at over US$81.6 billion in October 2018.<sup id="cite_ref-63" class="reference"><a href="#cite_note-63">[63]</a></sup> In 2018, 85% of the company's revenues came from just five products.<sup id="cite_ref-64" class="reference"><a href="#cite_note-64">[64]</a></sup> In 2018, Bristol-Myers Squibb spent 36% of its total revenue on R&amp;D expenses.<sup id="cite_ref-65" class="reference"><a href="#cite_note-65">[65]</a></sup> Bristol-Myers Squibb ranked 145th on the <a href="/wiki/Fortune_500" title="Fortune 500">Fortune 500</a> list of the largest United States corporations by revenue in 2018.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">[66]</a></sup></p>
<table class="wikitable float-left" style="text-align: right;"><tbody><tr><th>Year
</th>
<th>Revenue<br>in mil. USD$
</th>
<th>Net income<br>in mil. USD$
</th>
<th>Total assets<br>in mil. USD$
</th>
<th>Price per share<br>in USD$
</th>
<th>Employees
</th></tr><tr><td>2005
</td>
<td>18,605
</td>
<td>3,000
</td>
<td>28,138
</td>
<td>14.60
</td>
<td>
</td></tr><tr><td>2006
</td>
<td>16,208
</td>
<td>1,585
</td>
<td>25,575
</td>
<td>15.24
</td>
<td>
</td></tr><tr><td>2007
</td>
<td>15,617
</td>
<td>2,165
</td>
<td>25,926
</td>
<td>18.98
</td>
<td>
</td></tr><tr><td>2008
</td>
<td>17,715
</td>
<td>5,247
</td>
<td>29,486
</td>
<td>14.95
</td>
<td>
</td></tr><tr><td>2009
</td>
<td>18,808
</td>
<td>10,594
</td>
<td>31,008
</td>
<td>15.90
</td>
<td>
</td></tr><tr><td>2010
</td>
<td>19,484
</td>
<td>3,090
</td>
<td>31,076
</td>
<td>19.76
</td>
<td>
</td></tr><tr><td>2011
</td>
<td>21,244
</td>
<td>3,701
</td>
<td>32,970
</td>
<td>23.41
</td>
<td>
</td></tr><tr><td>2012
</td>
<td>17,621
</td>
<td>1,959
</td>
<td>35,897
</td>
<td>28.04
</td>
<td>
</td></tr><tr><td>2013
</td>
<td>16,385
</td>
<td>2,563
</td>
<td>38,592
</td>
<td>38.39
</td>
<td>28,000
</td></tr><tr><td>2014
</td>
<td>15,879
</td>
<td>2,004
</td>
<td>33,749
</td>
<td>47.03
</td>
<td>25,000
</td></tr><tr><td>2015
</td>
<td>16,560
</td>
<td>1,565
</td>
<td>31,748
</td>
<td>59.63
</td>
<td>25,000
</td></tr><tr><td>2016
</td>
<td>19,427
</td>
<td>4,457
</td>
<td>33,707
</td>
<td>59.73
</td>
<td>25,000
</td></tr><tr><td>2017
</td>
<td>20,776
</td>
<td>1,007
</td>
<td>33,551
</td>
<td>55.88
</td>
<td>23,700
</td></tr><tr><td>2018
</td>
<td>22,561
</td>
<td>4,920
</td>
<td>34,986
</td>
<td>51.98
</td>
<td>23,300
</td></tr></tbody></table></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(3)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Pharmaceuticals">Pharmaceuticals</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=10" title="Edit section: Pharmaceuticals" data-section="10" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-3 collapsible-block" id="mf-section-3">
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:HYDREA_(%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2).jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/67/HYDREA_%28%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2%29.jpg/170px-HYDREA_%28%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2%29.jpg" decoding="async" width="170" height="128" class="thumbimage" data-file-width="833" data-file-height="625"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 128px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/6/67/HYDREA_%28%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2%29.jpg/170px-HYDREA_%28%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2%29.jpg" data-alt="" data-width="170" data-height="128" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:HYDREA_(%E3%83%8F%E3%82%A4%E3%83%89%E3%83%AC%E3%82%A2).jpg" class="internal" title="Enlarge"></a></div>Hydrea (hydroxycarbamide)</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:112px;"><a href="/wiki/File:Atazanawir_300mg.jpg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/54/Atazanawir_300mg.jpg/110px-Atazanawir_300mg.jpg" decoding="async" width="110" height="110" class="thumbimage" data-file-width="450" data-file-height="450"></noscript><span class="lazy-image-placeholder" style="width: 110px;height: 110px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/5/54/Atazanawir_300mg.jpg/110px-Atazanawir_300mg.jpg" data-alt="" data-width="110" data-height="110" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Atazanawir_300mg.jpg" class="internal" title="Enlarge"></a></div>Reyataz (atazanavir)</div></div></div>
<p>The following is a list of key pharmaceutical products:<sup id="cite_ref-67" class="reference"><a href="#cite_note-67">[67]</a></sup></p>
<div class="div-col columns column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em;">
<p><i>Cardiovascular diseases</i>
</p>
<ul><li>Avalide (<a href="/wiki/Irbesartan" title="Irbesartan">irbesartan</a>/<a href="/wiki/Hydrochlorothiazide" title="Hydrochlorothiazide">hydrochlorothiazide</a>) – comarketed with <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a></li>
<li>Avapro (<a href="/wiki/Irbesartan" title="Irbesartan">irbesartan</a>) – comarketed with <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a></li>
<li>Coumadin (<a href="/wiki/Warfarin" title="Warfarin">warfarin</a>)</li>
<li>Eliquis (<a href="/wiki/Apixaban" title="Apixaban">apixaban</a>) – comarketed with <a href="/wiki/Pfizer" title="Pfizer">Pfizer</a></li>
<li>Plavix (<a href="/wiki/Clopidogrel" title="Clopidogrel">clopidogrel</a>) – comarketed with <a href="/wiki/Sanofi" title="Sanofi">Sanofi</a></li>
<li>Pravachol (<a href="/wiki/Pravastatin" title="Pravastatin">pravastatin</a>)</li></ul><p><i>Diabetes mellitus</i>
</p>
<ul><li>Bydureon (<a href="/wiki/Exenatide" title="Exenatide">exenatide</a> extended-release) – marketed by BMS only in some countries</li>
<li>Byetta (<a href="/wiki/Exenatide" title="Exenatide">exenatide</a>) – marketed by BMS only in some countries, such as <a href="/wiki/Russian_Federation" class="mw-redirect" title="Russian Federation">Russian Federation</a></li>
<li>Farxiga/Forxiga (<a href="/wiki/Dapagliflozin" title="Dapagliflozin">dapagliflozin</a>)</li>
<li>Glucophage (<a href="/wiki/Metformin" title="Metformin">metformin</a>) – marketed by BMS only in USA</li>
<li>Glucophage XR (<a href="/wiki/Metformin" title="Metformin">metformin</a> extended release) – marketed by BMS only in USA</li>
<li>Glucovance (<a href="/wiki/Glyburide/metformin" title="Glyburide/metformin">Glyburide/metformin</a>) – marketed by BMS only in USA</li>
<li>Kombiglyze XR/Komboglyze (<a href="/wiki/Saxagliptin" title="Saxagliptin">saxagliptin</a>/<a href="/wiki/Metformin" title="Metformin">metformin</a> extended release) – comarketed with <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a></li>
<li>Onglyza (<a href="/wiki/Saxagliptin" title="Saxagliptin">saxagliptin</a>) – comarketed with <a href="/wiki/AstraZeneca" title="AstraZeneca">AstraZeneca</a></li></ul><p><i>Infectious diseases, including <a href="/wiki/HIV/AIDS" title="HIV/AIDS">HIV infection</a> and associated conditions</i>
</p>
<ul><li><a href="/wiki/Atripla" class="mw-redirect" title="Atripla">Atripla</a> (<a href="/wiki/Efavirenz" title="Efavirenz">efavirenz</a>/<a href="/wiki/Emtricitabine" title="Emtricitabine">emtricitabine</a>/<a href="/wiki/Tenofovir_disoproxil_fumarate" class="mw-redirect" title="Tenofovir disoproxil fumarate">tenofovir disoproxil fumarate</a>) – comarketed with <a href="/wiki/Gilead_Sciences" title="Gilead Sciences">Gilead Sciences</a></li>
<li>Azactam (<a href="/wiki/Aztreonam" title="Aztreonam">aztreonam</a>)</li>
<li>Baraclude (<a href="/wiki/Entecavir" title="Entecavir">entecavir</a>)</li>
<li>Daklinza (<a href="/wiki/Daclatasvir" title="Daclatasvir">daclatasvir</a>)</li>
<li>Evotaz (<a href="/wiki/Atazanavir/cobicistat" title="Atazanavir/cobicistat">atazanavir/cobicistat</a>)</li>
<li>Megace (<a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li>
<li>Reyataz (<a href="/wiki/Atazanavir" title="Atazanavir">atazanavir</a>)</li>
<li>Sustiva/Stocrin (<a href="/wiki/Efavirenz" title="Efavirenz">efavirenz</a>)</li>
<li>Videx (<a href="/wiki/Didanosine" title="Didanosine">didanosine</a>)</li>
<li>Videx EC (<a href="/wiki/Didanosine" title="Didanosine">didanosine</a> delayed-release)</li>
<li>Zerit (<a href="/wiki/Stavudine" title="Stavudine">stavudine</a>)</li></ul><p><i>Inflammatory disorders</i>
</p>
<ul><li>Kenalog-10 (<a href="/wiki/Triamcinolone_acetonide" title="Triamcinolone acetonide">triamcinolone acetonide</a>)</li>
<li>Kenalog-40 (triamcinolone acetonide)</li></ul><p><i>Oncology</i>
</p>
<ul><li>BiCNU (<a href="/wiki/Carmustine" title="Carmustine">carmustine</a>)</li>
<li>CeeNU (<a href="/wiki/Lomustine" title="Lomustine">lomustine</a>)</li>
<li>Droxia/Hydrea (<a href="/wiki/Hydroxycarbamide" title="Hydroxycarbamide">hydroxycarbamide</a>)</li>
<li>Empliciti (<a href="/wiki/Elotuzumab" title="Elotuzumab">Elotuzumab</a>)</li>
<li>Erbitux (<a href="/wiki/Cetuximab" title="Cetuximab">cetuximab</a>)</li>
<li>Etopophos (<a href="/wiki/Etoposide" title="Etoposide">etoposide</a>)</li>
<li>Ixempra (<a href="/wiki/Ixabepilone" title="Ixabepilone">ixabepilone</a>)</li>
<li>Lysodren (<a href="/wiki/Mitotane" title="Mitotane">mitotane</a>)</li>
<li>Megace (<a href="/wiki/Megestrol_acetate" title="Megestrol acetate">megestrol acetate</a>)</li>
<li>Opdivo (<a href="/wiki/Nivolumab" title="Nivolumab">nivolumab</a>) is a <a href="/wiki/PD-1" class="mw-redirect" title="PD-1">programmed death receptor</a> blocking antibody used for the treatment of unresectable or metastatic melanoma and metastatic squamous <a href="/wiki/Non-small-cell_lung_carcinoma" title="Non-small-cell lung carcinoma">non-small-cell lung carcinoma</a>. In contrast to traditional chemotherapies and targeted anti-cancer therapies, which exert their effects by direct cytotoxic or tumor growth inhibition, nivolumab acts by inducing the immune system to attack the tumor.<sup id="cite_ref-68" class="reference"><a href="#cite_note-68">[68]</a></sup></li>
<li>Sprycel (<a href="/wiki/Dasatinib" title="Dasatinib">dasatinib</a>)</li>
<li>Taxol (<a href="/wiki/Paclitaxel" title="Paclitaxel">paclitaxel</a>). At one time, BMS held the solitary contract to harvest the bark of endangered <a href="/wiki/Taxus_brevifolia" title="Taxus brevifolia">yew</a> trees on United States territory for the manufacture of <a href="/wiki/Chemotherapy" title="Chemotherapy">chemotherapy</a> drug <a href="/wiki/Paclitaxel" title="Paclitaxel">paclitaxel</a> (Taxol). Current paclitaxel production comes from renewable sources.<sup class="noprint Inline-Template Template-Fact" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Citation_needed" title="Wikipedia:Citation needed"><span title="This claim needs references to reliable sources. (March 2015)">citation needed</span></a></i>]</sup> BMS also held the original paclitaxel license, but there are now multiple generic producers.<sup id="cite_ref-69" class="reference"><a href="#cite_note-69">[69]</a></sup></li>
<li>Vumon (<a href="/wiki/Teniposide" title="Teniposide">teniposide</a>)</li>
<li>Yervoy (<a href="/wiki/Ipilimumab" title="Ipilimumab">ipilimumab</a>)</li></ul><p><i>Psychiatry</i>
</p>
<ul><li>Abilify (<a href="/wiki/Aripiprazole" title="Aripiprazole">aripiprazole</a> comarketed with <a href="/wiki/Otsuka_Pharmaceutical" title="Otsuka Pharmaceutical">Otsuka Pharmaceutical</a>)</li></ul><p><i>Rheumatic disorders</i>
</p>
<ul><li>Orencia (<a href="/wiki/Abatacept" title="Abatacept">abatacept</a>)</li></ul><p><i>Transplant rejection</i>
</p>
<ul><li>Nulojix (<a href="/wiki/Belatacept" title="Belatacept">belatacept</a>)</li></ul></div>
<h3 class="in-block"><span class="mw-headline" id="Out_of_production">Out of production</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=11" title="Edit section: Out of production" data-section="11" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<ul><li><a href="/wiki/Sal_Hepatica" title="Sal Hepatica">Sal Hepatica</a></li>
<li><a href="/wiki/Ipana" title="Ipana">Ipana</a></li></ul><h3 class="in-block"><span class="mw-headline" id="Divested_brands">Divested brands</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=12" title="Edit section: Divested brands" data-section="12" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h3>
<p>(Former Bristol-Myers brands, now divested)
</p>
<ul><li><a href="/wiki/Bufferin" class="mw-redirect" title="Bufferin">Bufferin</a></li>
<li><a href="/wiki/Excedrin" class="mw-redirect" title="Excedrin">Excedrin</a><sup id="cite_ref-:4_57-1" class="reference"><a href="#cite_note-:4-57">[57]</a></sup></li>
<li><a href="/wiki/Mum_(deodorant)" title="Mum (deodorant)">Ban Deodorant</a></li>
<li><a href="/w/index.php?title=Vitalis_(hair_tonic)&amp;action=edit&amp;redlink=1" class="new" title="Vitalis (hair tonic) (page does not exist)">Vitalis (hair tonic)</a><sup id="cite_ref-:5_58-1" class="reference"><a href="#cite_note-:5-58">[58]</a></sup></li>
<li><a href="/w/index.php?title=Ammens&amp;action=edit&amp;redlink=1" class="new" title="Ammens (page does not exist)">Ammens</a> (medicated power)</li>
<li><a href="/w/index.php?title=Final_Net&amp;action=edit&amp;redlink=1" class="new" title="Final Net (page does not exist)">Final Net</a> (hair spray)</li>
<li><a href="/w/index.php?title=Comtrex&amp;action=edit&amp;redlink=1" class="new" title="Comtrex (page does not exist)">Comtrex</a> (cold relief capsules)</li>
<li><a href="/wiki/Keri" title="Keri">Keri</a> (lotion)<sup id="cite_ref-:6_59-1" class="reference"><a href="#cite_note-:6-59">[59]</a></sup></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(4)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Products_under_development">Products under development</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=13" title="Edit section: Products under development" data-section="13" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-4 collapsible-block" id="mf-section-4">
<div class="thumb tright"><div class="thumbinner" style="width:172px;"><a href="/wiki/File:Beclabuvir.svg" class="image"><noscript><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Beclabuvir.svg/170px-Beclabuvir.svg.png" decoding="async" width="170" height="110" class="thumbimage" data-file-width="512" data-file-height="332"></noscript><span class="lazy-image-placeholder" style="width: 170px;height: 110px;" data-src="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Beclabuvir.svg/170px-Beclabuvir.svg.png" data-alt="" data-width="170" data-height="110" data-srcset="//upload.wikimedia.org/wikipedia/commons/thumb/0/01/Beclabuvir.svg/255px-Beclabuvir.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/0/01/Beclabuvir.svg/340px-Beclabuvir.svg.png 2x" data-class="thumbimage"> </span></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Beclabuvir.svg" class="internal" title="Enlarge"></a></div>Beclabuvir</div></div></div>
<p>The following is a selective list of investigational products under development, as of 2015:<sup id="cite_ref-70" class="reference"><a href="#cite_note-70">[70]</a></sup></p>
<ul><li><a href="/wiki/Beclabuvir" title="Beclabuvir">Beclabuvir</a> (BMS-791325) – phase III</li>
<li><a href="/wiki/BMS-906024" title="BMS-906024">BMS-906024</a> – phase I</li>
<li><a href="/wiki/BMS-955176" title="BMS-955176">BMS-955176</a> – phase II</li>
<li><a href="/wiki/Brivanib_alaninate" title="Brivanib alaninate">Brivanib alaninate</a> (BMS-582664) – development terminated</li>
<li><a href="/wiki/Elotuzumab" title="Elotuzumab">Elotuzumab</a> (BMS-901608) – phase III</li>
<li><a href="/wiki/Fostemsavir" title="Fostemsavir">Fostemsavir</a> (BMS-663068) – phase III</li>
<li><a href="/wiki/Lirilumab" title="Lirilumab">Lirilumab</a> (BMS-986015)</li>
<li><a href="/wiki/Lulizumab_pegol" title="Lulizumab pegol">Lulizumab pegol</a> (BMS-931699) – phase II</li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(5)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Scandals">Scandals</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=14" title="Edit section: Scandals" data-section="14" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-5 collapsible-block" id="mf-section-5">
<p>Bristol-Myers Squibb, <a href="/wiki/Johns_Hopkins_University" title="Johns Hopkins University">Johns Hopkins University</a> and the <a href="/wiki/Rockefeller_Foundation" title="Rockefeller Foundation">Rockefeller Foundation</a> are currently the subject of a $1 billion lawsuit from <a href="/wiki/Guatemala" title="Guatemala">Guatemala</a> for "roles in a 1940s U.S. government experiment that infected hundreds of Guatemalans with <a href="/wiki/Syphilis" title="Syphilis">syphilis</a>".<sup id="cite_ref-71" class="reference"><a href="#cite_note-71">[71]</a></sup> A previous suit against the <a href="/wiki/United_States" title="United States">United States</a> government was dismissed in 2011 for the <a href="/wiki/Guatemala_syphilis_experiments" title="Guatemala syphilis experiments">Guatemala syphilis experiments</a> when a judge determined that the U.S. government could not be held liable for actions committed outside of the U.S.<sup id="cite_ref-72" class="reference"><a href="#cite_note-72">[72]</a></sup></p>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(6)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=15" title="Edit section: See also" data-section="15" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-6 collapsible-block" id="mf-section-6">
<ul><li><a href="/wiki/List_of_biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area" title="List of biotech and pharmaceutical companies in the New York metropolitan area">List of biotech and pharmaceutical companies in the New York metropolitan area</a></li></ul></section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(7)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="Notes_and_references">Notes and references</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=16" title="Edit section: Notes and references" data-section="16" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-7 collapsible-block" id="mf-section-7">
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="references"><li id="cite_note-10-K_2017-1"><span class="mw-cite-backlink"><b><a href="#cite_ref-10-K_2017_1-0">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.sec.gov/Archives/edgar/data/14272/000001427219000047/bmy-20181231x10xk.htm">"US SEC: Form 10-K Bristol-Myers Squibb Company"</a>. <a href="/wiki/U.S._Securities_and_Exchange_Commission" title="U.S. Securities and Exchange Commission">U.S. Securities and Exchange Commission</a><span class="reference-accessdate">. Retrieved <span class="nowrap">8 July</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=US+SEC%3A+Form+10-K+Bristol-Myers+Squibb+Company&amp;rft.pub=U.S.+Securities+and+Exchange+Commission&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2FArchives%2Fedgar%2Fdata%2F14272%2F000001427219000047%2Fbmy-20181231x10xk.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><style data-mw-deduplicate="TemplateStyles:r935243608">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png")no-repeat;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}</style></span>
</li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.bms.com/about-us/contact-us.html">"Bristol-Myers Squibb - Contact Us"</a>. 18 March 2020.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+-+Contact+Us&amp;rft.date=2020-03-18&amp;rft_id=https%3A%2F%2Fwww.bms.com%2Fabout-us%2Fcontact-us.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20120929024338/http://www.bmsi.co.in/bbrc.aspx?section=2">"Bristol-Myers Squibb and Biocon's Syngene open new R&amp;D Facility at Biocon Park"</a> (Press release). Archived from <a rel="nofollow" class="external text" href="http://www.bmsi.co.in/bbrc.aspx?section=2">the original</a> on 29 September 2012<span class="reference-accessdate">. Retrieved <span class="nowrap">16 May</span> 2012</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+and+Biocon%27s+Syngene+open+new+R%26D+Facility+at+Biocon+Park&amp;rft_id=http%3A%2F%2Fwww.bmsi.co.in%2Fbbrc.aspx%3Fsection%3D2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.fiercepharma.com/pharma/bristol-myers-squibb-to-lay-off-149-as-wallingford-site-nears-closure">"Bristol-Myers Squibb to lay off 149 as Wallingford, Connecticut, site nears closure"</a>. Fiercepharma.com<span class="reference-accessdate">. Retrieved <span class="nowrap">3 February</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+to+lay+off+149+as+Wallingford%2C+Connecticut%2C+site+nears+closure&amp;rft.pub=Fiercepharma.com&amp;rft_id=https%3A%2F%2Fwww.fiercepharma.com%2Fpharma%2Fbristol-myers-squibb-to-lay-off-149-as-wallingford-site-nears-closure&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><cite class="citation news">Gray, Christopher (30 August 2012). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2012/09/02/realestate/brooklyn-heights-streetscapes-still-in-fashion-a-century-later.html">"Still in Fashion, a Century Later"</a>. <i>The New York Times</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Still+in+Fashion%2C+a+Century+Later&amp;rft.date=2012-08-30&amp;rft.issn=0362-4331&amp;rft.aulast=Gray&amp;rft.aufirst=Christopher&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2012%2F09%2F02%2Frealestate%2Fbrooklyn-heights-streetscapes-still-in-fashion-a-century-later.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-6"><span class="mw-cite-backlink"><b><a href="#cite_ref-6">^</a></b></span> <span class="reference-text"><cite class="citation book">Kumar, B. (14 November 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=0lAjalmgNBUC&amp;newbks=0&amp;printsec=frontcover&amp;pg=PA54&amp;dq=squibb+corporation+%221858%22&amp;q=squibb+corporation+%221858%22&amp;hl=en"><i>Mega Mergers and Acquisitions: Case Studies from Key Industries</i></a>. Springer. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-137-00590-8" title="Special:BookSources/978-1-137-00590-8"><bdi>978-1-137-00590-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Mega+Mergers+and+Acquisitions%3A+Case+Studies+from+Key+Industries&amp;rft.pub=Springer&amp;rft.date=2012-11-14&amp;rft.isbn=978-1-137-00590-8&amp;rft.aulast=Kumar&amp;rft.aufirst=B.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D0lAjalmgNBUC%26newbks%3D0%26printsec%3Dfrontcover%26pg%3DPA54%26dq%3Dsquibb%2Bcorporation%2B%25221858%2522%26q%3Dsquibb%2Bcorporation%2B%25221858%2522%26hl%3Den&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-7"><span class="mw-cite-backlink"><b><a href="#cite_ref-7">^</a></b></span> <span class="reference-text"><cite class="citation book"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=nNgtGmY7iYIC&amp;lpg=PA192&amp;dq=Squibb%20was%20known%20as%20an%20advocate%20of%20quality%20control%20and%20high%20purity%20standards&amp;pg=PA192#v=onepage&amp;q=Squibb%20was%20known%20as%20an%20advocate%20of%20quality%20control%20and%20high%20purity%20standards&amp;f=false"><i>The National Druggist</i></a>. 1905.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=The+National+Druggist&amp;rft.date=1905&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DnNgtGmY7iYIC%26lpg%3DPA192%26dq%3DSquibb%2520was%2520known%2520as%2520an%2520advocate%2520of%2520quality%2520control%2520and%2520high%2520purity%2520standards%26pg%3DPA192%23v%3Donepage%26q%3DSquibb%2520was%2520known%2520as%2520an%2520advocate%2520of%2520quality%2520control%2520and%2520high%2520purity%2520standards%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.britannica.com/biography/E-R-Squibb">"E. R. Squibb | American chemist"</a>. <i>Encyclopedia Britannica</i><span class="reference-accessdate">. Retrieved <span class="nowrap">20 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Encyclopedia+Britannica&amp;rft.atitle=E.+R.+Squibb+%7C+American+chemist&amp;rft_id=https%3A%2F%2Fwww.britannica.com%2Fbiography%2FE-R-Squibb&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-9">^</a></b></span> <span class="reference-text"><cite class="citation journal">Hollopeter, W.C. (8 January 1885). <a rel="nofollow" class="external text" href="http://www.nejm.org/doi/full/10.1056/NEJM188710271171706">"Inverse Type of Temperature in Typhoid Fever, with a Report of Two Cases — Temperature Peculiarities in Epidemics, with a Report of Seven Cases in One Family"</a>. <i>Boston Medical and Surgical Journal</i>. <b>112</b>: 28–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM188308301090903">10.1056/NEJM188308301090903</a><span class="reference-accessdate">. Retrieved <span class="nowrap">25 November</span> 2014</span>. <q>The writer noticed (in December, 1882) the important fact that when common or Japan camphor and crystallized carbolic acid are mixed together and subjected to heat, a colorless liquid would be the result. The only reference he finds so far with regard to this reaction occurs in the very excellent and valuable scientific publication of Dr. E. R. Squibb, " Ephemeris of Materia Medica", etc., on page 673, vol. ii., No. 5, where a brief allusion appears under the appellation of Compound Alum Powder. Dr. F. R. Squibb, however, in a letter to the writer states that he has " several times before heard of this reaction between phenol and camphor.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Boston+Medical+and+Surgical+Journal&amp;rft.atitle=Inverse+Type+of+Temperature+in+Typhoid+Fever%2C+with+a+Report+of+Two+Cases+%E2%80%94+Temperature+Peculiarities+in+Epidemics%2C+with+a+Report+of+Seven+Cases+in+One+Family&amp;rft.volume=112&amp;rft.pages=28-32&amp;rft.date=1885-01-08&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM188308301090903&amp;rft.aulast=Hollopeter&amp;rft.aufirst=W.C.&amp;rft_id=http%3A%2F%2Fwww.nejm.org%2Fdoi%2Ffull%2F10.1056%2FNEJM188710271171706&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-10">^</a></b></span> <span class="reference-text"><cite class="citation journal">Worthen, Dennis (2003). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20140418052223/http://japha.org/article.aspx?articleid=1042039">"Edward Robinson Squibb (1819–1900): Advocate of Product Standards"</a>. <i>Journal of the American Pharmacists Association</i>. <b>46</b> (6): 754–758. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1331%2F1544-3191.46.6.754.Worthen">10.1331/1544-3191.46.6.754.Worthen</a>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/17176693">17176693</a>. Archived from <a rel="nofollow" class="external text" href="http://japha.org/article.aspx?articleid=1042039">the original</a> on 18 April 2014<span class="reference-accessdate">. Retrieved <span class="nowrap">25 November</span> 2014</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Pharmacists+Association&amp;rft.atitle=Edward+Robinson+Squibb+%281819%E2%80%931900%29%3A+Advocate+of+Product+Standards&amp;rft.volume=46&amp;rft.issue=6&amp;rft.pages=754-758&amp;rft.date=2003&amp;rft_id=info%3Adoi%2F10.1331%2F1544-3191.46.6.754.Worthen&amp;rft_id=info%3Apmid%2F17176693&amp;rft.aulast=Worthen&amp;rft.aufirst=Dennis&amp;rft_id=http%3A%2F%2Fjapha.org%2Farticle.aspx%3Farticleid%3D1042039&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-11">^</a></b></span> <span class="reference-text"><cite class="citation journal">Blake, J.B. (1899). <a rel="nofollow" class="external text" href="https://zenodo.org/record/1916260">"Administration of Ether at the Boston City Hospital"</a>. <i>Boston Med Surg J</i>. <b>141</b> (13): 312–314. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2FNEJM189909281411303">10.1056/NEJM189909281411303</a>. <q>Until within six months Squibb's other has been exclusively used at the Boston City Hospital. Recently .MeliiHTéift's ether has been tried, ¡uni has given fair satisfaction ; Squibb's is still preferred by most of the house officers.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Boston+Med+Surg+J&amp;rft.atitle=Administration+of+Ether+at+the+Boston+City+Hospital&amp;rft.volume=141&amp;rft.issue=13&amp;rft.pages=312-314&amp;rft.date=1899&amp;rft_id=info%3Adoi%2F10.1056%2FNEJM189909281411303&amp;rft.aulast=Blake&amp;rft.aufirst=J.B.&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1916260&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-12"><span class="mw-cite-backlink"><b><a href="#cite_ref-12">^</a></b></span> <span class="reference-text"><cite class="citation journal">Brown, W.S. (1885). <a rel="nofollow" class="external text" href="https://zenodo.org/record/1429884">"Forty Year's Experience in Midwifery"</a>. <i>Boston Medical and Surgical Journal</i>. <b>112</b> (11): 241. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1056%2Fnejm188503121121101">10.1056/nejm188503121121101</a>. <q>One reason why ergot has fallen into disrepute is the poor quality of many specimens offered for sale. Dr. Squibb's aqueous extract rarely disappoints me.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Boston+Medical+and+Surgical+Journal&amp;rft.atitle=Forty+Year%27s+Experience+in+Midwifery&amp;rft.volume=112&amp;rft.issue=11&amp;rft.pages=241&amp;rft.date=1885&amp;rft_id=info%3Adoi%2F10.1056%2Fnejm188503121121101&amp;rft.aulast=Brown&amp;rft.aufirst=W.S.&amp;rft_id=https%3A%2F%2Fzenodo.org%2Frecord%2F1429884&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-13">^</a></b></span> <span class="reference-text"><cite class="citation book">Capace, Nancy (1 January 2001). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=u9StYwbI_F8C&amp;lpg=PA227&amp;dq=U.S.%20Pharmacopeia%20Squibb's%20Ephemeris%20of%20Materia%20Medica&amp;pg=PA227#v=onepage&amp;q=U.S.%20Pharmacopeia%20Squibb's%20Ephemeris%20of%20Materia%20Medica&amp;f=false"><i>Encyclopedia of Delaware</i></a>. Somerset Publishers, Inc. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-403-09612-1" title="Special:BookSources/978-0-403-09612-1"><bdi>978-0-403-09612-1</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Encyclopedia+of+Delaware&amp;rft.pub=Somerset+Publishers%2C+Inc.&amp;rft.date=2001-01-01&amp;rft.isbn=978-0-403-09612-1&amp;rft.aulast=Capace&amp;rft.aufirst=Nancy&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3Du9StYwbI_F8C%26lpg%3DPA227%26dq%3DU.S.%2520Pharmacopeia%2520Squibb%27s%2520Ephemeris%2520of%2520Materia%2520Medica%26pg%3DPA227%23v%3Donepage%26q%3DU.S.%2520Pharmacopeia%2520Squibb%27s%2520Ephemeris%2520of%2520Materia%2520Medica%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><cite class="citation book">Smith (2001). <span class="cs1-lock-registration" title="Free registration required"><a rel="nofollow" class="external text" href="https://archive.org/details/medicinesforunio00smit"><i>Medicines for the Union Army: the United States Army laboratories during the Civil War</i></a></span>. Pharmaceutical Products Press.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Medicines+for+the+Union+Army%3A+the+United+States+Army+laboratories+during+the+Civil+War&amp;rft.pub=Pharmaceutical+Products+Press&amp;rft.date=2001&amp;rft.au=Smith&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fmedicinesforunio00smit&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"> Accessed 2014-11-25.</span>
</li>
<li id="cite_note-15"><span class="mw-cite-backlink"><b><a href="#cite_ref-15">^</a></b></span> <span class="reference-text"><cite class="citation book"><a rel="nofollow" class="external text" href="https://books.google.com/books?id=ueAJxIW6gu0C&amp;lpg=RA3-PA27&amp;dq=Bristol-Myers%20Squibb%20union%20army&amp;pg=RA3-PA24#v=onepage&amp;q=Bristol-Myers%20Squibb%20union%20army&amp;f=false"><i>Navy Medicine</i></a>. Naval Medical Command. 2005.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Navy+Medicine&amp;rft.pub=Naval+Medical+Command&amp;rft.date=2005&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DueAJxIW6gu0C%26lpg%3DRA3-PA27%26dq%3DBristol-Myers%2520Squibb%2520union%2520army%26pg%3DRA3-PA24%23v%3Donepage%26q%3DBristol-Myers%2520Squibb%2520union%2520army%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-16">^</a></b></span> <span class="reference-text"><cite class="citation book">Rosenbloom, Bert (25 July 2012). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=6WMJAAAAQBAJ&amp;lpg=PA609&amp;pg=PA609#v=snippet&amp;q=1944&amp;f=false"><i>Marketing Channels</i></a> (in German). Cengage Learning. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-1-133-70757-8" title="Special:BookSources/978-1-133-70757-8"><bdi>978-1-133-70757-8</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Marketing+Channels&amp;rft.pub=Cengage+Learning&amp;rft.date=2012-07-25&amp;rft.isbn=978-1-133-70757-8&amp;rft.aulast=Rosenbloom&amp;rft.aufirst=Bert&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D6WMJAAAAQBAJ%26lpg%3DPA609%26pg%3DPA609%23v%3Dsnippet%26q%3D1944%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-MarketingChannels-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-MarketingChannels_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MarketingChannels_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text">Bert Rosenbloom, <i>Marketing Channels</i>, <a rel="nofollow" class="external text" href="https://books.google.com/books?id=6WMJAAAAQBAJ&amp;pg=PA609">Bristol-Myers Squibb</a>, 2011, page 609</span>
</li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reporterherald.com/ci_30933687/ipana-toothpaste-tasted-success-early-1900s">"Ipana toothpaste tasted success in early 1900s"</a>. <i>Loveland Reporter-Herald</i>. 20 April 2017<span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Loveland+Reporter-Herald&amp;rft.atitle=Ipana+toothpaste+tasted+success+in+early+1900s&amp;rft.date=2017-04-20&amp;rft_id=https%3A%2F%2Fwww.reporterherald.com%2Fci_30933687%2Fipana-toothpaste-tasted-success-early-1900s&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-19">^</a></b></span> <span class="reference-text"><cite class="citation news">Salpukas, Agis (16 August 1984). <a rel="nofollow" class="external text" href="https://www.nytimes.com/1984/08/16/business/business-people-3-executive-changes-set-by-bristol-myers.html">"BUSINESS PEOPLE; 3 Executive Changes Set by Bristol-Myers"</a>. <i>The New York Times</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=BUSINESS+PEOPLE%3B+3+Executive+Changes+Set+by+Bristol-Myers&amp;rft.date=1984-08-16&amp;rft.issn=0362-4331&amp;rft.aulast=Salpukas&amp;rft.aufirst=Agis&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F1984%2F08%2F16%2Fbusiness%2Fbusiness-people-3-executive-changes-set-by-bristol-myers.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-20">^</a></b></span> <span class="reference-text"><cite class="citation book">Botti, Timothy J. (2006). <a rel="nofollow" class="external text" href="https://books.google.com/books?id=4UPo0V1qovwC&amp;lpg=PA250&amp;dq=Squibb%20world's%20largest%20penicillin%20plant%20for%20army&amp;pg=PA250#v=onepage&amp;q=Squibb%20world's%20largest%20penicillin%20plant%20for%20army&amp;f=false"><i>Envy of the World: A History of the U.S. Economy &amp; Big Business</i></a>. Algora Publishing. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a> <a href="/wiki/Special:BookSources/978-0-87586-432-7" title="Special:BookSources/978-0-87586-432-7"><bdi>978-0-87586-432-7</bdi></a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Envy+of+the+World%3A+A+History+of+the+U.S.+Economy+%26+Big+Business&amp;rft.pub=Algora+Publishing&amp;rft.date=2006&amp;rft.isbn=978-0-87586-432-7&amp;rft.aulast=Botti&amp;rft.aufirst=Timothy+J.&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3D4UPo0V1qovwC%26lpg%3DPA250%26dq%3DSquibb%2520world%27s%2520largest%2520penicillin%2520plant%2520for%2520army%26pg%3DPA250%23v%3Donepage%26q%3DSquibb%2520world%27s%2520largest%2520penicillin%2520plant%2520for%2520army%26f%3Dfalse&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-21"><span class="mw-cite-backlink"><b><a href="#cite_ref-21">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://fortune.com/2014/06/02/fortune-500-bristol-myers/">"Bristol-Myers Squibb: Big Pharma's small wonder"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">10 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Bristol-Myers+Squibb%3A+Big+Pharma%27s+small+wonder&amp;rft_id=https%3A%2F%2Ffortune.com%2F2014%2F06%2F02%2Ffortune-500-bristol-myers%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-22"><span class="mw-cite-backlink"><b><a href="#cite_ref-22">^</a></b></span> <span class="reference-text"><cite class="citation news">Harris, Gardiner (19 January 2009). <a rel="nofollow" class="external text" href="https://www.nytimes.com/2009/01/20/health/policy/20drug.html">"Drug Making's Move Abroad Stirs Concerns"</a>. <i>The New York Times</i>. <a href="/wiki/International_Standard_Serial_Number" title="International Standard Serial Number">ISSN</a> <a rel="nofollow" class="external text" href="//www.worldcat.org/issn/0362-4331">0362-4331</a><span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+New+York+Times&amp;rft.atitle=Drug+Making%E2%80%99s+Move+Abroad+Stirs+Concerns&amp;rft.date=2009-01-19&amp;rft.issn=0362-4331&amp;rft.aulast=Harris&amp;rft.aufirst=Gardiner&amp;rft_id=https%3A%2F%2Fwww.nytimes.com%2F2009%2F01%2F20%2Fhealth%2Fpolicy%2F20drug.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.latimes.com/archives/la-xpm-1989-07-28-fi-295-story.html">"Bristol-Myers, Squibb Agree to Merge : $12-Billion Stock Swap Would Form 2nd-Largest Drug Firm"</a>. <i>Los Angeles Times</i>. 28 July 1989<span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Los+Angeles+Times&amp;rft.atitle=Bristol-Myers%2C+Squibb+Agree+to+Merge+%3A+%2412-Billion+Stock+Swap+Would+Form+2nd-Largest+Drug+Firm&amp;rft.date=1989-07-28&amp;rft_id=https%3A%2F%2Fwww.latimes.com%2Farchives%2Fla-xpm-1989-07-28-fi-295-story.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-24">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.nationalmedals.org/laureates/bristol-myers-squibb-company">"NSTMF"</a>. <i>NSTMF</i><span class="reference-accessdate">. Retrieved <span class="nowrap">26 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=NSTMF&amp;rft.atitle=NSTMF&amp;rft_id=https%3A%2F%2Fwww.nationalmedals.org%2Flaureates%2Fbristol-myers-squibb-company&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://money.cnn.com/2002/06/04/news/companies/bristol">"Bristol hit with antitrust suit"</a>. <i>CNN</i>. 4 June 2002<span class="reference-accessdate">. Retrieved <span class="nowrap">10 July</span> 2013</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=CNN&amp;rft.atitle=Bristol+hit+with+antitrust+suit&amp;rft.date=2002-06-04&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2002%2F06%2F04%2Fnews%2Fcompanies%2Fbristol&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://www.sec.gov/litigation/litreleases/lr18822.htm">"Bristol-Myers Squibb Company : Lit. Rel. No. 18822"</a> (Press release). US Securities and Exchange Commission. 6 August 2004<span class="reference-accessdate">. Retrieved <span class="nowrap">9 May</span> 2015</span>. <q>Bristol-Myers inflated its results primarily by: (1) stuffing its distribution channels with excess inventory near the end of every quarter in amounts sufficient to meet sales and earnings targets set by officers ("channel-stuffing")</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+Company+%3A+Lit.+Rel.+No.+18822&amp;rft.pub=US+Securities+and+Exchange+Commission&amp;rft.date=2004-08-06&amp;rft_id=https%3A%2F%2Fwww.sec.gov%2Flitigation%2Flitreleases%2Flr18822.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-27"><span class="mw-cite-backlink"><b><a href="#cite_ref-27">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20131105214250/http://www.highbeam.com/doc/1P1-68980061.html">"Bristol-Myers to restate earnings as third quarter profits plunge"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.highbeam.com/doc/1P1-68980061.html">the original</a> on 5 November 2013.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+to+restate+earnings+as+third+quarter+profits+plunge&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1P1-68980061.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-28">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20150924182701/http://www.highbeam.com/doc/1P1-92165333.html">"Bristol-Myers restates results upward due to accounting errors"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.highbeam.com/doc/1P1-92165333.html">the original</a> on 24 September 2015.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+restates+results+upward+due+to+accounting+errors&amp;rft_id=http%3A%2F%2Fwww.highbeam.com%2Fdoc%2F1P1-92165333.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.busrep.co.za/index.php?fSectionId=565&amp;fArticleId=3367635">Business Report</a> <a rel="nofollow" class="external text" href="https://web.archive.org/web/20070817193955/http://www.busrep.co.za/index.php?fSectionId=565&amp;fArticleId=3367635">Archived</a> 17 August 2007 at the <a href="/wiki/Wayback_Machine" title="Wayback Machine">Wayback Machine</a>, July 31, 2006. Retrieved September 7, 2006. Archived at</span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://money.cnn.com/2006/09/12/news/companies/bristol/index.htm?postversion=2006091217">CNN.com</a>, September 12, 2006. Retrieved September 12, 2006</span>
</li>
<li id="cite_note-:1-31"><span class="mw-cite-backlink">^ <a href="#cite_ref-:1_31-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:1_31-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:1_31-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-:1_31-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Wright, Rob (October 2018). <a rel="nofollow" class="external text" href="https://www.qgdigitalpublishing.com/publication/?i=531504&amp;p=&amp;pn=#%7B%22issue_id%22:531504,%22page%22:20%7D">"From Big to Specialty—The Operational Transformation of Bristol-Myers Squibb"</a>. <i>Life Science Leader</i>. <b>10</b> (10). Erie, Pennsylvania: VertMarkets<span class="reference-accessdate">. Retrieved <span class="nowrap">17 October</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Life+Science+Leader&amp;rft.atitle=From+Big+to+Specialty%26mdash%3BThe+Operational+Transformation+of+Bristol-Myers+Squibb&amp;rft.volume=10&amp;rft.issue=10&amp;rft.date=2018-10&amp;rft.aulast=Wright&amp;rft.aufirst=Rob&amp;rft_id=https%3A%2F%2Fwww.qgdigitalpublishing.com%2Fpublication%2F%3Fi%3D531504%26p%3D%26pn%3D%23%7B%2522issue_id%2522%3A531504%2C%2522page%2522%3A20%7D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:0-32"><span class="mw-cite-backlink">^ <a href="#cite_ref-:0_32-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:0_32-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-:0_32-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Staff (15 February 2015). "BMS CEO Andreotti to Retire; COO named as Successor". <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Genetic Engineering &amp; Biotechnology News</a></i> (paper). <b>35</b> (4). p. 6.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=BMS+CEO+Andreotti+to+Retire%3B+COO+named+as+Successor&amp;rft.volume=35&amp;rft.issue=4&amp;rft.pages=6&amp;rft.date=2015-02-15&amp;rft.au=Staff&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><cite class="citation news">Herper, Matthew (31 December 2013). <a rel="nofollow" class="external text" href="https://www.forbes.com/sites/matthewherper/2013/12/31/grading-pharma-in-2013-16-drug-companies-ranked/">"Grading Pharma in 2013"</a>. <i>Forbes</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Forbes&amp;rft.atitle=Grading+Pharma+in+2013&amp;rft.date=2013-12-31&amp;rft.aulast=Herper&amp;rft.aufirst=Matthew&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmatthewherper%2F2013%2F12%2F31%2Fgrading-pharma-in-2013-16-drug-companies-ranked%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><cite class="citation news">Anna Edney (22 December 2014). <a rel="nofollow" class="external text" href="https://www.bloomberg.com/news/2014-12-22/bristol-myers-drug-wins-u-s-approval-to-treat-advanced-melanoma.html">"Bristol-Myers Drug Wins U.S. Approval to Treat Advanced Melanoma"</a>. Bloomberg.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bristol-Myers+Drug+Wins+U.S.+Approval+to+Treat+Advanced+Melanoma&amp;rft.date=2014-12-22&amp;rft.au=Anna+Edney&amp;rft_id=https%3A%2F%2Fwww.bloomberg.com%2Fnews%2F2014-12-22%2Fbristol-myers-drug-wins-u-s-approval-to-treat-advanced-melanoma.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-35">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bavarian-nordic-could-tally-up-to-975m-in-prostate-cancer-deal-with-bms/81250993/">"Bavarian Nordic Could Tally up to $975 Million in Prostate Cancer Deal with BMS – GEN News Highlights – GEN"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=Bavarian+Nordic+Could+Tally+up+to+%24975+Million+in+Prostate+Cancer+Deal+with+BMS+%E2%80%93+GEN+News+Highlights+%E2%80%93+GEN&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbavarian-nordic-could-tally-up-to-975m-in-prostate-cancer-deal-with-bms%2F81250993%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-ABC_News-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-ABC_News_36-0">^</a></b></span> <span class="reference-text"><cite class="citation web">Johnson, Linda A. <a rel="nofollow" class="external text" href="http://abcnews.go.com/Business/wireStory/ceo-takes-drugmaker-bristol-myers-squibb-30816845">"New CEO Takes Over Evolving Drugmaker Bristol-Myers Squibb"</a>. ABC News<span class="reference-accessdate">. Retrieved <span class="nowrap">6 May</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=New+CEO+Takes+Over+Evolving+Drugmaker+Bristol-Myers+Squibb&amp;rft.pub=ABC+News&amp;rft.aulast=Johnson&amp;rft.aufirst=Linda+A.&amp;rft_id=http%3A%2F%2Fabcnews.go.com%2FBusiness%2FwireStory%2Fceo-takes-drugmaker-bristol-myers-squibb-30816845&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/2017/02/21/carl-icahn-bristol-myers-squibb/">"Bristol-Myers Squibb Shares Just Spiked on Reports of a Carl Icahn Stake"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 May</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Bristol-Myers+Squibb+Shares+Just+Spiked+on+Reports+of+a+Carl+Icahn+Stake&amp;rft_id=http%3A%2F%2Ffortune.com%2F2017%2F02%2F21%2Fcarl-icahn-bristol-myers-squibb%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><cite class="citation web">Benoit, David; Rockoff, Jonathan D. (22 February 2017). <a rel="nofollow" class="external text" href="https://www.wsj.com/articles/carl-icahn-takes-stake-in-bristol-myers-squibb-1487710151">"Carl Icahn Takes Stake in Bristol-Myers Squibb"</a>. <i>Wall Street Journal</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 May</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Wall+Street+Journal&amp;rft.atitle=Carl+Icahn+Takes+Stake+in+Bristol-Myers+Squibb&amp;rft.date=2017-02-22&amp;rft.aulast=Benoit&amp;rft.aufirst=David&amp;rft.au=Rockoff%2C+Jonathan+D.&amp;rft_id=https%3A%2F%2Fwww.wsj.com%2Farticles%2Fcarl-icahn-takes-stake-in-bristol-myers-squibb-1487710151&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.fiercepharma.com/m-a/gilead-s-m-a-intentions-include-oncology-inflammation-ceo">"Making (good) deals is hard to do, Gilead CEO says, but he's working on it – FiercePharma"</a>. <i>fiercepharma.com</i><span class="reference-accessdate">. Retrieved <span class="nowrap">23 May</span> 2017</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=fiercepharma.com&amp;rft.atitle=Making+%28good%29+deals+is+hard+to+do%2C+Gilead+CEO+says%2C+but+he%27s+working+on+it+%E2%80%93+FiercePharma&amp;rft_id=http%3A%2F%2Fwww.fiercepharma.com%2Fm-a%2Fgilead-s-m-a-intentions-include-oncology-inflammation-ceo&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><cite class="citation web">LaVito, Angelica (26 April 2018). <a rel="nofollow" class="external text" href="https://www.cnbc.com/2018/04/26/bristol-myers-squibb-q1-earnings-2018.html">"Bristol-Myers' cancer drug Opdivo fuels growth, but revenue falls short"</a>. CNBC<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers%27+cancer+drug+Opdivo+fuels+growth%2C+but+revenue+falls+short&amp;rft.pub=CNBC&amp;rft.date=2018-04-26&amp;rft.aulast=LaVito&amp;rft.aufirst=Angelica&amp;rft_id=https%3A%2F%2Fwww.cnbc.com%2F2018%2F04%2F26%2Fbristol-myers-squibb-q1-earnings-2018.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-41">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://finance.yahoo.com/news/BristolMyers-Squibb-to-bw-571310065.html?x=0&amp;.v=1">https://finance.yahoo.com/news/BristolMyers-Squibb-to-bw-571310065.html?x=0&amp;.v=1</a><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since February 2019">permanent dead link</span></a></i>]</span></sup></span>
</li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://news.businessweek.com/article.asp?documentKey=1376-LXGOIL0UQVI901-5RJORL8I6BNJBGJ76B844E0GQP">"Bristol Buys Inhibitex for $2.5 Billion to Compete in Hepatitis"</a>. 8 January 2012.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol+Buys+Inhibitex+for+%242.5+Billion+to+Compete+in+Hepatitis&amp;rft.date=2012-01-08&amp;rft_id=http%3A%2F%2Fnews.businessweek.com%2Farticle.asp%3FdocumentKey%3D1376-LXGOIL0UQVI901-5RJORL8I6BNJBGJ76B844E0GQP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template"><span style="white-space: nowrap;">[<i><a href="/wiki/Wikipedia:Link_rot" title="Wikipedia:Link rot"><span title=" Dead link since November 2018">permanent dead link</span></a></i>]</span></sup></span>
</li>
<li id="cite_note-:2-43"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_43-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_43-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Gershberg, Michele (30 June 2012). <a rel="nofollow" class="external text" href="http://uk.reuters.com/article/2012/06/30/uk-amylin-bristolmyerssquibb-idUKBRE85T01U20120630">"Bristol-Myers to buy Amylin for about USD 5.3 billion"</a>. Reuters.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Bristol-Myers+to+buy+Amylin+for+about+USD+5.3+billion&amp;rft.date=2012-06-30&amp;rft.aulast=Gershberg&amp;rft.aufirst=Michele&amp;rft_id=http%3A%2F%2Fuk.reuters.com%2Farticle%2F2012%2F06%2F30%2Fuk-amylin-bristolmyerssquibb-idUKBRE85T01U20120630&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bms-acquires-ipierian-for-up-to-725m/81249801/">"Bristol-Myers to buy iPierian"</a>. <i>Genetic Engineering &amp; biotechnology news</i>. 29 April 2014.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+biotechnology+news&amp;rft.atitle=Bristol-Myers+to+buy+iPierian&amp;rft.date=2014-04-29&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbms-acquires-ipierian-for-up-to-725m%2F81249801%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bms-deals-add-to-its-immuno-oncology-portfolio/81250955/">"GEN – News Highlights:BMS Deals Add to its Immuno-Oncology Portfolio"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=GEN+%E2%80%93+News+Highlights%3ABMS+Deals+Add+to+its+Immuno-Oncology+Portfolio&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbms-deals-add-to-its-immuno-oncology-portfolio%2F81250955%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-46">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bms-to-buy-cardioxyl-for-up-to-2-075b/81251924/">"BMS to Buy Cardioxyl for Up to $2.075B"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=BMS+to+Buy+Cardioxyl+for+Up+to+%242.075B&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbms-to-buy-cardioxyl-for-up-to-2-075b%2F81251924%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-47">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bms-to-acquire-padlock-therapeutics-for-up-to-600m/81252509/">"BMS to Acquire Padlock Therapeutics for Up to $600M"</a>. <i>GEN</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=GEN&amp;rft.atitle=BMS+to+Acquire+Padlock+Therapeutics+for+Up+to+%24600M&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbms-to-acquire-padlock-therapeutics-for-up-to-600m%2F81252509%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-genengaug2016-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-genengaug2016_48-0">^</a></b></span> <span class="reference-text"><cite class="citation journal"><a rel="nofollow" class="external text" href="http://www.genengnews.com/gen-news-highlights/bms-acquires-cormorant-pharmaceuticals-for-up-to-520m/81252909/">"BMS Snags Cormorant Pharmaceuticals for Up to $520M (online title: BMS Acquires Cormorant Pharmaceuticals for Up to $520M)"</a>. News: Industry Watch (online: GEN News Highlights). <i><a href="/wiki/Gen._Eng._Biotechnol._News" class="mw-redirect" title="Gen. Eng. Biotechnol. News">Genetic Engineering &amp; Biotechnology News</a></i>. <b>36</b> (14): 10. August 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Genetic+Engineering+%26+Biotechnology+News&amp;rft.atitle=BMS+Snags+Cormorant+Pharmaceuticals+for+Up+to+%24520M+%28online+title%3A+BMS+Acquires+Cormorant+Pharmaceuticals+for+Up+to+%24520M%29&amp;rft.volume=36&amp;rft.issue=14&amp;rft.pages=10&amp;rft.date=2016-08&amp;rft_id=http%3A%2F%2Fwww.genengnews.com%2Fgen-news-highlights%2Fbms-acquires-cormorant-pharmaceuticals-for-up-to-520m%2F81252909%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><cite class="citation web">Editorial, Reuters. <a rel="nofollow" class="external text" href="http://uk.reuters.com/article/us-ifm-therapeutics-m-a-bristol-myers-idUKKBN1AJ2Z1">"Bristol-Myers to buy IFM Therapeutics to strengthen cancer pipeline"</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+to+buy+IFM+Therapeutics+to+strengthen+cancer+pipeline&amp;rft.aulast=Editorial&amp;rft.aufirst=Reuters&amp;rft_id=http%3A%2F%2Fuk.reuters.com%2Farticle%2Fus-ifm-therapeutics-m-a-bristol-myers-idUKKBN1AJ2Z1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://uk.reuters.com/article/uk-celgene-m-a-bristol-myers/celgene-bristol-myers-set-2-2-billion-termination-fee-for-their-mega-deal-idUKKCN1OY1CA">https://uk.reuters.com/article/uk-celgene-m-a-bristol-myers/celgene-bristol-myers-set-2-2-billion-termination-fee-for-their-mega-deal-idUKKCN1OY1CA</a></span>
</li>
<li id="cite_note-51"><span class="mw-cite-backlink"><b><a href="#cite_ref-51">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.bloomberg.com/news/articles/2019-01-03/bristol-myers-squibb-to-buy-celgene-in-74-billion-pharma-deal">https://www.bloomberg.com/news/articles/2019-01-03/bristol-myers-squibb-to-buy-celgene-in-74-billion-pharma-deal</a></span>
</li>
<li id="cite_note-:3-52"><span class="mw-cite-backlink">^ <a href="#cite_ref-:3_52-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:3_52-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news">Herbst-Bayliss, Svea; Erman, Michael (28 February 2019). <a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-celgene-m-a-bristol-myers-wellington/celgene-slumps-as-bristol-myers-shareholder-resists-merger-idUSKCN1QH1K7">"Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal"</a>. Reuters<span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2019</span>. <q>Starboard reported on Thursday that it now owns 4.4 million shares, or 0.3 percent of Bristol’s outstanding shares, while Wellington owns an 8 percent stake.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Starboard+joins+opposition+to+Bristol-Myers%27+%2474+billion+Celgene+deal&amp;rft.date=2019-02-28&amp;rft.aulast=Herbst-Bayliss&amp;rft.aufirst=Svea&amp;rft.au=Erman%2C+Michael&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-celgene-m-a-bristol-myers-wellington%2Fcelgene-slumps-as-bristol-myers-shareholder-resists-merger-idUSKCN1QH1K7&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-53">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.bloomberg.com/news/articles/2019-01-03/bristol-myers-squibb-to-buy-celgene-in-74-billion-pharma-deal">https://www.bloomberg.com/news/articles/2019-01-03/bristol-myers-squibb-to-buy-celgene-in-74-billion-pharma-deal</a></span>
</li>
<li id="cite_note-54"><span class="mw-cite-backlink"><b><a href="#cite_ref-54">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb-shareholders-approve-celgene-acquisition">Bristol-Myers Squibb Shareholders Approve Celgene Acquisition</a>, PM BMS April 12, 2019, retrieved May 13, 2019</span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.europeanpharmaceuticalreview.com/news/106288/bristol-myers-squibb-completes-acquisition-of-celgene/">"Bristol-Myers Squibb completes acquisition of Celgene"</a>. <i>European Pharmaceutical Review</i>. 22 November 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=European+Pharmaceutical+Review&amp;rft.atitle=Bristol-Myers+Squibb+completes+acquisition+of+Celgene&amp;rft.date=2019-11-22&amp;rft_id=https%3A%2F%2Fwww.europeanpharmaceuticalreview.com%2Fnews%2F106288%2Fbristol-myers-squibb-completes-acquisition-of-celgene%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://pharmabiz.com/ArticleDetails.aspx?aid=116689&amp;sid=2">"Bristol-Myers Squibb completes divestment of consumer health business, UPSA to Taisho Pharma"</a>. <i>Pharmabiz.com</i> (Churnalism). India: Saffron Media. 2 July 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">4 July</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmabiz.com&amp;rft.atitle=Bristol-Myers+Squibb+completes+divestment+of+consumer+health+business%2C+UPSA+to+Taisho+Pharma&amp;rft.date=2019-07-02&amp;rft_id=http%3A%2F%2Fpharmabiz.com%2FArticleDetails.aspx%3Faid%3D116689%26sid%3D2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:4-57"><span class="mw-cite-backlink">^ <a href="#cite_ref-:4_57-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:4_57-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation news"><a rel="nofollow" class="external text" href="http://money.cnn.com/2005/01/12/news/fortune500/bristol/index.htm">"Excedrin brand for sale"</a>. News &gt; Fortune 500. CNN Money. Reuters. 12 January 2005.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Excedrin+brand+for+sale&amp;rft.date=2005-01-12&amp;rft_id=http%3A%2F%2Fmoney.cnn.com%2F2005%2F01%2F12%2Fnews%2Ffortune500%2Fbristol%2Findex.htm&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-:5-58"><span class="mw-cite-backlink">^ <a href="#cite_ref-:5_58-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:5_58-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20160304115627/https://www.prnewswire.com/news-releases/bristol-myers-squibb-to-divest-three-consumer-brands-76664287.html">"Bristol-Myers Squibb to Divest Three Consumer Brands"</a> (Press release). Bristol-Myers Squibb Company. 21 September 1998. Archived from <a rel="nofollow" class="external text" href="http://www.prnewswire.com/news-releases/bristol-myers-squibb-to-divest-three-consumer-brands-76664287.html">the original</a> on 4 March 2016 – via PRNewswire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+to+Divest+Three+Consumer+Brands&amp;rft.pub=Bristol-Myers+Squibb+Company&amp;rft.date=1998-09-21&amp;rft_id=http%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fbristol-myers-squibb-to-divest-three-consumer-brands-76664287.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability#Self-published_sources" title="Wikipedia:Verifiability"><span title="The material near this tag may rely on a self-published source. (July 2019)">self-published source</span></a></i>]</sup></span>
</li>
<li id="cite_note-:6-59"><span class="mw-cite-backlink">^ <a href="#cite_ref-:6_59-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:6_59-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><cite class="citation pressrelease"><a rel="nofollow" class="external text" href="http://www.businesswire.com/news/home/20081211005659/en/Bristol-Myers-Squibb-Plans-Divest-U.S.-Canadian-Consumer">"Bristol-Myers Squibb Plans To Divest U.S. And Canadian Consumer Medicines Business"</a> (Press release). Bristol-Myers Squibb. 12 January 2005 – via BusinessWire.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+Plans+To+Divest+U.S.+And+Canadian+Consumer+Medicines+Business&amp;rft.pub=Bristol-Myers+Squibb&amp;rft.date=2005-01-12&amp;rft_id=http%3A%2F%2Fwww.businesswire.com%2Fnews%2Fhome%2F20081211005659%2Fen%2FBristol-Myers-Squibb-Plans-Divest-U.S.-Canadian-Consumer&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"><sup class="noprint Inline-Template" style="white-space:nowrap;">[<i><a href="/wiki/Wikipedia:Verifiability#Self-published_sources" title="Wikipedia:Verifiability"><span title="The material near this tag may rely on a self-published source. (July 2019)">self-published source</span></a></i>]</sup></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://www.biospace.com/article/releases/amgen-to-acquire-otezla-for-13-4-billion-in-cash-or-approximately-11-2-billion-net-of-anticipated-future-cash-tax-benefits/?s=79">https://www.biospace.com/article/releases/amgen-to-acquire-otezla-for-13-4-billion-in-cash-or-approximately-11-2-billion-net-of-anticipated-future-cash-tax-benefits/?s=79</a></span>
</li>
<li id="cite_note-61"><span class="mw-cite-backlink"><b><a href="#cite_ref-61">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external free" href="https://uk.reuters.com/article/us-bristol-myers-divestiture-amgen/celgene-to-sell-psoriasis-drug-otezla-for-13-4-billion-to-amgen-idUKKCN1VG102">https://uk.reuters.com/article/us-bristol-myers-divestiture-amgen/celgene-to-sell-psoriasis-drug-otezla-for-13-4-billion-to-amgen-idUKKCN1VG102</a></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.biopharmadive.com/news/bristol-myers-biomotive-launch-anteros-biotech/571650/">"Bristol-Myers launches biotech targeting fibrosis, inflammation"</a>. <i>BioPharma Dive</i><span class="reference-accessdate">. Retrieved <span class="nowrap">3 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=BioPharma+Dive&amp;rft.atitle=Bristol-Myers+launches+biotech+targeting+fibrosis%2C+inflammation&amp;rft_id=https%3A%2F%2Fwww.biopharmadive.com%2Fnews%2Fbristol-myers-biomotive-launch-anteros-biotech%2F571650%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-63"><span class="mw-cite-backlink"><b><a href="#cite_ref-63">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.macrotrends.net/stocks/charts/BMY/bristol-myers-squibb/revenue">"Bristol-Myers Squibb Revenue 2006-2018 | BMY"</a>. <i>macrotrends.net</i><span class="reference-accessdate">. Retrieved <span class="nowrap">31 October</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=macrotrends.net&amp;rft.atitle=Bristol-Myers+Squibb+Revenue+2006-2018+%7C+BMY&amp;rft_id=https%3A%2F%2Fwww.macrotrends.net%2Fstocks%2Fcharts%2FBMY%2Fbristol-myers-squibb%2Frevenue&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.logistics.dhl/global-en/home/about-us/delivered-magazine/articles/2019/issue-3-2019/bristol-myers-squibb-diversity-scale-biopharma.html">"Bristol-Myers Squibb: Diversity and scale in biopharma"</a>. <i>DHL</i>. June 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=DHL&amp;rft.atitle=Bristol-Myers+Squibb%3A+Diversity+and+scale+in+biopharma&amp;rft.date=2019-06&amp;rft_id=https%3A%2F%2Fwww.logistics.dhl%2Fglobal-en%2Fhome%2Fabout-us%2Fdelivered-magazine%2Farticles%2F2019%2Fissue-3-2019%2Fbristol-myers-squibb-diversity-scale-biopharma.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-65"><span class="mw-cite-backlink"><b><a href="#cite_ref-65">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.forbes.com/sites/greatspeculations/2019/11/28/what-percent-does-bristol-myers-squibb-spend-on-rd-30-40-or-50/">"What Percent Does Bristol-Myers Squibb Spend On R&amp;D, 30%, 40%, Or 50%?"</a>. <i>Forbes</i>. 28 November 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">11 December</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Forbes&amp;rft.atitle=What+Percent+Does+Bristol-Myers+Squibb+Spend+On+R%26D%2C+30%25%2C+40%25%2C+Or+50%25%3F&amp;rft.date=2019-11-28&amp;rft_id=https%3A%2F%2Fwww.forbes.com%2Fsites%2Fgreatspeculations%2F2019%2F11%2F28%2Fwhat-percent-does-bristol-myers-squibb-spend-on-rd-30-40-or-50%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://fortune.com/fortune500/bristol-myers-squibb/">"Bristol-Myers Squibb"</a>. <i>Fortune</i><span class="reference-accessdate">. Retrieved <span class="nowrap">20 November</span> 2018</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=Fortune&amp;rft.atitle=Bristol-Myers+Squibb&amp;rft_id=http%3A%2F%2Ffortune.com%2Ffortune500%2Fbristol-myers-squibb%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.bms.com/products/Pages/home.aspx">"Selected Products of Bristol-Myers Squibb"</a>. © 2015 Bristol-Myers Squibb Company<span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Selected+Products+of+Bristol-Myers+Squibb&amp;rft.pub=%C2%A9+2015+Bristol-Myers+Squibb+Company&amp;rft_id=http%3A%2F%2Fwww.bms.com%2Fproducts%2FPages%2Fhome.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-68">^</a></b></span> <span class="reference-text"><cite class="citation journal">Johnson DB, Peng C, Sosman JA (2015). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4346215">"Nivolumab in melanoma: latest evidence and clinical potential"</a>. <i>Ther Adv Med Oncol</i>. <b>7</b> (2): 97–106. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1177%2F1758834014567469">10.1177/1758834014567469</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a> <span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC4346215">4346215</a></span>. <a href="/wiki/PubMed_Identifier" class="mw-redirect" title="PubMed Identifier">PMID</a> <a rel="nofollow" class="external text" href="//pubmed.ncbi.nlm.nih.gov/25755682">25755682</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ther+Adv+Med+Oncol&amp;rft.atitle=Nivolumab+in+melanoma%3A+latest+evidence+and+clinical+potential&amp;rft.volume=7&amp;rft.issue=2&amp;rft.pages=97-106&amp;rft.date=2015&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4346215&amp;rft_id=info%3Apmid%2F25755682&amp;rft_id=info%3Adoi%2F10.1177%2F1758834014567469&amp;rft.aulast=Johnson&amp;rft.aufirst=DB&amp;rft.au=Peng%2C+C&amp;rft.au=Sosman%2C+JA&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4346215&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.drugs.com/availability/generic-taxol.html">"Generic Taxol Availability"</a>. <i>drugs.com</i>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=drugs.com&amp;rft.atitle=Generic+Taxol+Availability&amp;rft_id=https%3A%2F%2Fwww.drugs.com%2Favailability%2Fgeneric-taxol.html&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.bms.com/research/pipeline/Pages/default.aspx">"Bristol-Myers Squibb: the Pipeline"</a>. © 2015 Bristol-Myers Squibb Company<span class="reference-accessdate">. Retrieved <span class="nowrap">30 May</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb%3A+the+Pipeline&amp;rft.pub=%C2%A9+2015+Bristol-Myers+Squibb+Company&amp;rft_id=http%3A%2F%2Fwww.bms.com%2Fresearch%2Fpipeline%2FPages%2Fdefault.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-71">^</a></b></span> <span class="reference-text"><cite class="citation web"><a rel="nofollow" class="external text" href="https://www.reuters.com/article/us-maryland-lawsuit-infections-idUSKCN1OY1N3">"Johns Hopkins, Bristol-Myers must face $1 billion syphilis infections suit"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Johns+Hopkins%2C+Bristol-Myers+must+face+%241+billion+syphilis+infections+suit&amp;rft_id=https%3A%2F%2Fwww.reuters.com%2Farticle%2Fus-maryland-lawsuit-infections-idUSKCN1OY1N3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
<li id="cite_note-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-72">^</a></b></span> <span class="reference-text"><cite class="citation news">Mariani, Mike (28 May 2015). <a rel="nofollow" class="external text" href="https://psmag.com/news/the-guatemala-experiments">"The Guatemala Experiments"</a>. <i>Pacific Standard</i>. The Miller-McCune Center for Research, Media and Public Policy<span class="reference-accessdate">. Retrieved <span class="nowrap">7 January</span> 2015</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pacific+Standard&amp;rft.atitle=The+Guatemala+Experiments&amp;rft.date=2015-05-28&amp;rft.aulast=Mariani&amp;rft.aufirst=Mike&amp;rft_id=https%3A%2F%2Fpsmag.com%2Fnews%2Fthe-guatemala-experiments&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></span>
</li>
</ol></div>
</section><h2 class="section-heading" onclick="javascript:mfTempOpenSection(8)"><div class="mw-ui-icon mw-ui-icon-element indicator mw-ui-icon-small mw-ui-icon-flush-left"></div><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><a href="/w/index.php?title=Bristol-Myers_Squibb&amp;action=edit&amp;section=17" title="Edit section: External links" data-section="17" class="mw-ui-icon mw-ui-icon-element mw-ui-icon-wikimedia-edit-base20 edit-page mw-ui-icon-flush-right">Edit</a></span></h2><section class="mf-section-8 collapsible-block" id="mf-section-8">
<table role="presentation" class="mbox-small plainlinks sistersitebox" style="background-color:#f9f9f9;border:1px solid #aaa;color:#000"><tbody><tr>
<td class="mbox-text plainlist">Wikimedia Commons has media related to <i><b><a href="https://commons.wikimedia.org/wiki/Category:Bristol-Myers_Squibb" class="extiw" title="commons:Category:Bristol-Myers Squibb"><span style="">Bristol-Myers Squibb</span></a></b></i>.</td></tr></tbody></table><ul><li><a rel="nofollow" class="external text" href="https://www.bms.com/about-us/our-company/worldwide-facilities.html#westwindsor">Bristol-Myers Squibb worldwide locations</a></li>
<li><cite class="citation web"><a rel="nofollow" class="external text" href="http://www.drugstorenews.com/article/bristol-myers-squibb-donates-69-million-benefit-cancer-patients">"Bristol-Myers Squibb donates $6.9 million to benefit cancer patient"</a>. Drugstorenews.com.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Bristol-Myers+Squibb+donates+%246.9+million+to+benefit+cancer+patient&amp;rft.pub=Drugstorenews.com&amp;rft_id=http%3A%2F%2Fwww.drugstorenews.com%2Farticle%2Fbristol-myers-squibb-donates-69-million-benefit-cancer-patients&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ABristol-Myers+Squibb" class="Z3988"></span><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r935243608"></li>
<li>Business data for Bristol-Myers Squibb: <div class="hlist hlist-separated inline"><ul><li><a rel="nofollow" class="external text" href="https://www.google.com/finance?q=BMY">Google Finance</a></li><li><a rel="nofollow" class="external text" href="https://finance.yahoo.com/q?s=BMY">Yahoo! Finance</a></li><li><a rel="nofollow" class="external text" href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=BMY">SEC filings</a></li></ul></div></li></ul>




</section></div><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1&amp;mobile=1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;oldid=951494000">https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;oldid=951494000</a>"</div>
</div>
			<div class="post-content" id="page-secondary-actions">
			
			</div>
		</main>
		<footer class="minerva-footer">
		<div class="last-modified-bar">
	<div class="post-content last-modified-bar__content">
		<span class="last-modified-bar__icon mw-ui-icon mw-ui-icon-mw-ui-icon-small mw-ui-icon-wikimedia-history-base20 "></span>
		<a class="last-modified-bar__text" href="/wiki/Special:History/Bristol-Myers_Squibb"
				data-user-name="He309"
				data-user-gender="unknown"
				data-timestamp="1587128374">
				<span>Last edited on 17 April 2020, at 12:59</span>
		</a>
		<span class="mw-ui-icon mw-ui-icon-small mw-ui-icon-mf-expand-gray mf-mw-ui-icon-rotate-anti-clockwise indicator"></span>
	</div>
</div>

		<div class="post-content footer-content">
			<div id='mw-data-after-content'>
	<div class="read-more-container"></div>
</div>

			<h2><img src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" width="116" height="18" alt="Wikipedia"/></h2>
			<div class="license">Content is available under <a class="external" rel="nofollow" href="https://creativecommons.org/licenses/by-sa/3.0/">CC BY-SA 3.0</a> unless otherwise noted.</div>
			<ul class="footer-places hlist hlist-separated">
				<li id="footer-places-terms-use"><a href="//m.wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a></li><li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Privacy_policy" class="extiw" title="wmf:Privacy policy">Privacy</a></li><li id="footer-places-desktop-toggle"><a id="mw-mf-display-toggle" href="//en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb&amp;mobileaction=toggle_view_desktop">Desktop</a></li>
			</ul>
		</div>
		</footer>
	</div>
</div>
<div class="mw-notification-area" data-mw="interface"></div>
<!-- v:8.3.0 -->

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"limitreport":{"cputime":"0.964","walltime":"1.243","ppvisitednodes":{"value":5507,"limit":1000000},"postexpandincludesize":{"value":180616,"limit":2097152},"templateargumentsize":{"value":10214,"limit":2097152},"expansiondepth":{"value":17,"limit":40},"expensivefunctioncount":{"value":14,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":206664,"limit":5000000},"entityaccesscount":{"value":4,"limit":400},"timingprofile":["100.00% 1076.653      1 -total"," 44.57%  479.883      1 Template:Reflist"," 18.24%  196.421      1 Template:Infobox_company"," 17.43%  187.638     32 Template:Cite_web"," 16.86%  181.567      1 Template:Infobox","  8.08%   87.036     14 Template:Cite_news","  7.32%   78.853      8 Template:Wikidata","  6.89%   74.142      1 Template:Br_separated_entries","  6.00%   64.616      1 Template:Short_description","  5.69%   61.260      6 Template:Cite_journal"]},"scribunto":{"limitreport-timeusage":{"value":"0.497","limit":"10.000"},"limitreport-memusage":{"value":9871708,"limit":52428800}},"cachereport":{"origin":"mw1403","timestamp":"20200417125937","ttl":2592000,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Bristol-Myers Squibb","url":"https:\/\/en.wikipedia.org\/wiki\/Bristol-Myers_Squibb","sameAs":"http:\/\/www.wikidata.org\/entity\/Q266423","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q266423","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-03-01T12:13:27Z","dateModified":"2020-04-17T12:59:34Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/a\/a6\/Bristolmyersprincetonfacility.jpg","headline":"American pharmaceutical company"}</script><script>(window.NORLQ=window.NORLQ||[]).push(function(){var ns,i,p,img;ns=document.getElementsByTagName('noscript');for(i=0;i<ns.length;i++){p=ns[i].nextSibling;if(p&&p.className&&p.className.indexOf('lazy-image-placeholder')>-1){img=document.createElement('img');img.setAttribute('src',p.getAttribute('data-src'));img.setAttribute('width',p.getAttribute('data-width'));img.setAttribute('height',p.getAttribute('data-height'));img.setAttribute('alt',p.getAttribute('data-alt'));p.parentNode.replaceChild(img,p);}}});</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgBackendResponseTime":140,"wgHostname":"mw1411"});});</script>		</body>
		</html>
		